The National Health Service (General Medical Services) Regulations 1992

SCHEDULE 1 PROVISIONS CONFERRING POWERS EXERCISED IN MAKING THESE REGULATIONS (1)(2)

(1)	(2)
Provision	Relevant amendments
National Health Service Act 1977(1)—
section 7(2)(a)	Health Services Act 1980(2) (“the 1980 Act”), Schedule 1, paragraphs 35 and 90;
section 15(1)	Health and Social Security Act 1984(3) (“the xmlns="http://www.tso.co.uk/assets/namespace/legislation" 1984 Act”), section 5(2) and Schedule 8;
	National Health Service and Community Care Act 1990(4) (“the 1990 Act”), section 12;
section 16(1)(b)	The 1980 Act, Schedule 1, Part I, paragraph 36(a);
section 29(5)	The 1980 Act, section 7 and Schedule 1, paragraphs 42 and 93; Health and Social Services and Social Security Adjudications Act 1983(6), Schedule 6, paragraph 2; Family Practitioner Committees (Consequential Modifications) Order 1985(7) (“the 1985 Order”), article 7(3);
section 30(1)	1980 Act, Schedule 1, paragraph 43(a) and Schedule 7; European Communities (Medical, Dental and Nursing Professions) (Linguistic Knowledge) Order 1981(8), article 3(1)(a); 1985 Order, article 7(4);
section 31(1)	1985 Order, article 7(5);
section 33(2A), (4)	1985 Order, article 7(7); 1990 Act, section 23;
section 34	1985 Order, article 7(8); 1990 Act, section 23;
section 45(1)	1984 Act, Schedule 3, paragraph 7(a);
section 50
section 126(4)	1990 Act, section 65(2);
section 127(a)
section 128(1) (definitions of “prescribed” and “regulations”)	1990 Act, section 26(2);
Schedule 5, paragraph 12(b) and (c)
Schedule 10, paragraph 1(3)
Health and Medicines Act 1988 section 8(1)(a) and (5)

Regulation 3(2)

SCHEDULE 2 TERMS OF SERVICE FOR DOCTORS

1. 1–2. Interpretation

2. 3. General

3. 4–5. A doctor’s patients

4. 6–8. Acceptance of patients

5. 9–11. Termination of responsibility for patients

6. 12–17. Services to patients generally and for specified purposes

7. 18–26. Absences, deputies, assistants and partners

8. 27. Arrangements at practice premises

9. 28. Employees

10. 29–33. Doctors' availability to patients

11. 34. Practice area

12. 35. Notification of change of place of residence

13. 36. Records

14. 37. Certification

15. 38–42. Fees

16. 43–46. Prescribing

17. 47. Practice leaflet

18. 48. Reports etc to the medical officer

19. 49. Inquiries about prescriptions and referrals

20. 50. Annual reports

21. 51. Incorporation of provisions of regulations, etc

Interpretation

1.  In this Schedule, unless the context otherwise requires—

“appliance” means an appliance which is included in a list for the time being approved by the Secretary of State for the purposes of section 41 of the Act(9);

“assistant” includes a trainee general practitioner;

“chemical reagent” means a chemical reagent which is included in a list for the time being approved by the Secretary of State for the purposes of section 41 of the Act;

“deputy” means a person to whom a doctor has, under paragraph 19, delegated the treatment of his patient;

“deputising service” means any person or body carrying on a business which is concerned with the provision of a deputy or deputies for doctors for periods which do not normally exceed 48 hours;

“drugs” includes medicines;

“Drug Tariff” means the statement published under regulation 18 of the Pharmaceutical Regulations;

“post-natal period” means the period of 14 days following the conclusion of a pregnancy;

“prescription form” means a form provided by a health authority, an FHSA or, where the doctor is in the medical list of more than one FHSA, by the FHSA which is responsible for the supply of that form, and issued by a doctor to enable a person to obtain pharmaceutical services;

“Scheduled drug” means a drug or other substance specified in Schedule 10 or, except where the conditions in paragraph 44(2) are satisfied, in Schedule 11;

2.  Unless the context otherwise requires, any reference in a paragraph in this Schedule to a numbered sub-paragraph is a reference to the sub-paragraph bearing that number in that paragraph.

General

3.  Where a decision whether any, and if so what, action is to be taken under these terms of service requires the exercise of professional judgment, a doctor shall not, in reaching that decision, be expected to exercise a higher degree of skill, knowledge and care than—

(a) in the case of a doctor providing child health surveillance services under regulation 28, maternity medical services under regulation 31 or minor surgery services under regulation 33, that which any general practitioner included in the child health surveillance list, the obstetric list or, as the case may be, the minor surgery list may reasonably be expected to exercise; and

(b) in any other case, that which general practitioners as a class may reasonably be expected to exercise.

A doctor’s patients

4.—(1) Subject to sub-paragraph (2) and to paragraphs 9, 10 and 11, a doctor’s patients are—

(a) persons who are recorded by the FHSA as being on his list;

(b) persons whom he has accepted or agreed to accept on his list, whether or not notification of that acceptance has been received by the FHSA, and who have not been notified to him by the FHSA as having ceased to be on his list;

(c) for the limited period specified in sub-paragraph (4), persons whom he has refused to accept;

(d) persons who have been assigned to him under regulation 21;

(e) for the limited period specified in sub-paragraph (5), persons in respect of whom he has been notified that an application has been made for assignment to him in a case to which regulation 21(3)(b) applies;

(f) persons whom he has accepted as temporary residents;

(g) in respect of services under paragraph 8, persons to whom he has agreed to provide those services;

(h) persons to whom he may be requested to give treatment which is immediately required owing to an accident or other emergency at any place in his practice area, provided that—

(i) he is not, at time of the request, relieved of liability to give treatment under paragraph 5, and

(ii) he is not, at the time of the request, relieved, under paragraph 19(2), of his obligation to give treatment personally, and

(iii) he is available to provide such treatment,

and any persons by whom he is requested, and agrees, to give treatment which is immediately required owing to an accident or other emergency at any place in the locality of any FHSA in whose medical list he is included, provided there is no doctor who, at the time of the request, is under an obligation otherwise than under this head to give treatment to that person, or there is such a doctor but, after being requested to attend, he is unable to attend and give treatment immediately required;

(i) persons in relation to whom he is acting as deputy for another doctor under these terms of service;

(j) during the period of an appointment under regulation 25, persons whom he has been appointed to treat temporarily;

(k) in respect of child health surveillance services, contraceptive services, maternity medical services, or minor surgery services persons for whom he has undertaken to provide such services; and

(l) during the hours arranged with the FHSA, any person whose own doctor has been relieved of responsibility during those hours under paragraph 19 and for whom he has accepted responsibility under that paragraph.

(2) Except in a case to which head (h), (i) or (j) of sub-paragraph (1) applies, no person shall be a patient for the purposes of that sub-paragraph if the doctor has been notified by the FHSA that he is no longer responsible for the treatment of that person.

(3) Where a person applies to a doctor for treatment and claims to be on that doctor’s list, but fails to produce his medical card on request and the doctor has reasonable doubts about that person’s claim, the doctor shall give any necessary treatment and shall be entitled to demand and accept a fee accordingly under paragraph 38(f), subject to the provision for repayment contained in paragraph 39.

(4) Where a doctor refuses to accept for inclusion on his list a person who lives in his practice area and who is not on the list of another doctor practising in that area, or refuses to accept as a temporary resident a person to whom regulation 26 applies, he shall on request give that person any immediately necessary treatment for one period not exceeding 14 days from the date when that person was refused acceptance or until that person has been accepted by or assigned to another doctor, whichever period is the shorter.

(5) Where the FSHA has notified a doctor that it is applying for the Secretary of State’s consent under regulation 21(3)(b), the doctor shall give the person proposed for assignment any immediately necessary treatment until the FHSA has notified him that—

(a) the Secretary of State has determined whether or not the person is to be assigned to that doctor; and

(b) either the person has been accepted by, or assigned to, another doctor or another doctor has been notified that an application has been made, in a case to which regulation 21(3)(b) applies, to assign that person to him.

5.  A doctor who is elderly or infirm or who has been exempted by the FHSA under regulation 21(11) from the liability to have persons assigned to him, may be relieved by the FHSA of any liability to give treatment which is immediately required owing to an accident or other emergency between 7pm on weekdays and 8am on the following morning and between 1pm on Saturday and 8am on the following Monday to persons who are neither—

(a) on his list; nor

(b) temporary residents for whom he is responsible; nor

(c) accepted by him for the provision of maternity medical services.

Acceptance of patients

6.—(1) Subject to sub-paragraph (2), a doctor may agree to accept a person on his list if the person is eligible to be accepted by him.

(2) Where a doctor is responsible for treating the patients of another doctor whose name has been removed from the medical list, he may not consent to the transfer of any of those patients under regulation 22 to his own list or to that of his partner.

(3) Where a doctor has agreed to accept a person on his list, he shall, within 14 days of receiving that person’s medical card or form of application, or as soon after the expiry of that period as is practicable—

(a) sign the medical card or, as the case may be, the form of application; and

(b) send it to the FHSA.

(4) Where, for the purposes of sub-paragraph (3), any person signs a medical card or form of application on behalf of a doctor he shall, in addition to his own signature, specify the name of the doctor on whose behalf he is signing.

7.  A doctor may—

(a) undertake to provide contraceptive services to a woman who has applied to him in accordance with regulation 29;

(b) accept as a temporary resident a person who has applied to him in accordance with regulation 26(1);

(c) undertake to provide maternity medical services to a woman who has made an arrangement with him in accordance with regulation 31(2).

8.  Notwithstanding that the person concerned is not on his list, a doctor may—

(a) take a cervical smear from a woman who would be eligible for acceptance by him as a temporary resident or for whom he has undertaken to provide maternity medical services or contraceptive services; and

(b) vaccinate or immunise a person who would be eligible for acceptance by him as a temporary resident.

Termination of responsibility for patients

9.—(1) A doctor may have any person removed from his list and shall notify the FHSA in writing that he wishes to have a person removed from his list and, subject to sub-paragraph (2), the removal shall take effect—

(a) on the date on which the person is accepted by or assigned to another doctor; or

(b) on the eighth day after the FHSA receives the notice,

whichever is the sooner.

(2) Where, at the date when the removal would take effect under sub-paragraph (1), the doctor is treating the person at intervals of less than 7 days, the doctor shall inform the FHSA in writing of the fact and the removal shall take effect—

(a) on the eighth day after the FHSA receives notification from the doctor that the person no longer needs such treatment; or

(b) on the date on which the person is accepted by or assigned to another doctor,

whichever is the sooner.

10.  Where a doctor informs the FHSA in writing that he wishes to terminate his responsibility for a temporary resident, his responsibility for that person shall cease in accordance with paragraph 9, as if the temporary resident were a person on his list.

11.—(1) A doctor with whom an arrangement has been made for the provision of any or all of the maternity medical services mentioned in regulation 31(1)(a) may agree with the woman concerned to terminate the arrangement, and in default of agreement the doctor may apply to the FHSA for permission to terminate the arrangement.

(2) On an application under paragraph (1), the FHSA, after considering any representations made by either party and after consulting the Local Medical Committee, may terminate the arrangement.

(3) Where a doctor ceases to provide any or all of the maternity medical services mentioned in regulation 31(1)(a), he shall inform any woman for whom he has arranged to provide such services that he is ceasing to provide them and that she may make a fresh arrangement to receive those services from another doctor.

Services to patients

12.—(1) Subject to paragraphs 3, 13 and 44, a doctor shall render to his patients all necessary and appropriate personal medical services of the type usually provided by general medical practitioners.

(2) The services which a doctor is required by sub-paragraph (1) to render shall include the following:

(a) giving advice, where appropriate, to a patient in connection with the patient’s general health, and in particular about the significance of diet, exercise, the use of tobacco, the consumption of alcohol and the misuse of drugs or solvents;

(b) offering to patients consultations and, where appropriate, physical examinations for the purpose of identifying, or reducing the risk of, disease or injury;

(c) offering to patients, where appropriate, vaccination or immunisation against measles, mumps, rubella, pertussis, poliomyelitis, diphtheria and tetanus;

(d) arranging for the referral of patients, as appropriate, for the provision of any other services under the Act; and

(e) giving advice, as appropriate, to enable patients to avail themselves of services provided by a local social services authority.

(3) A doctor is not required by sub-paragraph (1) or (2)—

(a) to provide to any person child health surveillance services, contraceptive services, minor surgery services nor, except in an emergency, maternity medical services, unless he has previously undertaken to the FHSA to provide such services to that person; or

(b) where he is a restricted services principal, to provide any category of general medical services which he has not undertaken to provide.

Provision of services to patients

13.  The services referred to in paragraph 12 shall be rendered by a doctor—

(a) at his practice premises;

(b) if the condition of the patient so requires—

(i) at the place where the patient was residing when he was accepted by the doctor pursuant to paragraph 6 or, as the case may be, when he was assigned to the doctor pursuant to regulation 21 or, in the case of a patient who was previously on the list of a doctor in a practice declared vacant, when the doctor succeeded to the vacancy,

(ii) at such other place as the doctor has informed the patient and the FHSA is the place where he has agreed to visit and treat the patient if the patient’s condition so requires, or

(iii) in any other case, at some other place in the doctor’s practice area; or

(c) at such places and at such times as have been approved by the FHSA in his case, pursuant to paragraph 29.

Newly registered patients

14.—(1) Subject to sub-paragraphs (4) to (9), where a patient has been accepted on a doctor’s list under paragraph 6 or assigned to a doctor’s list under regulation 21, the doctor shall, in addition to and without prejudice to his other obligations in respect of that patient under these terms of service, within 28 days of the date of such acceptance or assignment invite the patient to participate in a consultation either at his practice premises or, if the condition of the patient so warrants, at such other place as the doctor is obliged under paragraph 13(b) to render personal medical services to that patient.

(2) Where a patient (or, in the case of a patient who is a child, his parent) agrees to participate in a consultation mentioned in sub-paragraph (1), the doctor shall, in the course of that consultation—

(a) seek details from the patient as to his medical history and, so far as may be relevant to the patient’s medical history, as to that of his consanguineous family, in respect of—

(i) illnesses, immunisations, allergies, hereditary conditions, medication and tests carried out for breast or cervical cancer,

(ii) social factors (including employment, housing and family circumstances) which may affect his health,

(iii) factors of his lifestyle (including diet, exercise, use of tobacco, consumption of alcohol, and misuse of drugs or solvents) which may affect his health, and

(iv) the current state of his health;

(b) offer to undertake a physical examination of the patient, comprising—

(i) the measurement of his height, weight and blood pressure, and

(ii) the taking of a urine sample and its analysis to identify the presence of albumen and glucose;

(c) record, in the patient’s medical records, his findings arising out of the details supplied by, and any examination of, the patient under this sub-paragraph;

(d) assess whether and, if so, in what manner and to what extent he should render personal medical services to the patient;

(e) in so far as it would not, in the opinion of the doctor, be likely to cause serious damage to the physical or mental health of the patient to do so, offer to discuss with the patient (or, where the patient is a child, the parent) the conclusions the doctor has drawn as a result of the consultation as to the state of the patient’s health.

(3) On each occasion where a doctor invites a patient or parent to participate in a consultation pursuant to sub-paragraph (1) he shall—

(a) make the invitation in writing or, if the invitation is initially made orally, confirm it in writing, by a letter either handed to the patient or his representative or sent to the patient or parent at the address recorded in his medical records as being his last home address;

(b) record in the patient’s medical records the date of each such invitation and whether or not it was accepted; and

(c) where, as a result of making the invitation, the doctor becomes aware that the patient is no longer residing at the address shown in his medical records, advise the FHSA accordingly.

(4) A doctor shall not be obliged to offer a consultation pursuant to sub-paragraph (1)—

(a) if he is a restricted services principal;

(b) in respect of a child under the age of 5 years;

(c) to any patient who, immediately before joining the list of the doctor, was a patient of a partner of the doctor and who, during the 12 months immediately preceding the date of his acceptance or assignment to the doctor’s list, had participated in a consultation pursuant to sub-paragraph (1); or

(d) to the extent allowed by the FHSA, to any patient within a class of patients in respect of which the FHSA or, on appeal, the Secretary of State has, pursuant to sub-paragraphs (5) to (8), deferred the doctor’s obligation under sub-paragraph (1).

(5) Where a doctor assumes responsibility for a list of patients on his succession to a practice declared vacant, or otherwise becomes responsible for a significant number of new patients within a short period, he may apply, in accordance with sub-paragraph (6), to the FHSA for the deferment of his obligation under sub-paragraph (1) for a period not exceeding 2 years from the date of the application.

(6) An application pursuant to sub-paragraph (5) shall be made in writing and shall be accompanied by a statement of the doctor’s proposals, by reference to particular classes of patient, with a view to securing that all eligible patients are invited to participate in a consultation pursuant to sub-paragraph (1) by the end of the period of the deferment.

(7) Within 2 months of receiving an application the FHSA shall determine it—

(a) by approving the application;

(b) by approving the application subject to conditions; or

(c) by refusing the application.

(8) A doctor may appeal in writing to the Secretary of State against any refusal of an application, or against any condition subject to which an application is approved by the FHSA pursuant to sub-paragraph (7)(b), and on determining such an appeal the Secretary of State shall either confirm the FHSA’s decision or substitute his own determination for that of the FHSA.

(9) The Secretary of State shall notify the doctor in writing of his determination and shall include with the notice a statement of his reasons for it.

Patients not seen within 3 years

15.—(1) Subject to sub-paragraph (2), a doctor shall, in addition to and without prejudice to any other obligation under these terms of service, invite each patient on his list who appears to him—

(a) to have attained the age of 16 years but who has not attained the age of 75 years; and

(b) to have neither—

(i) within the preceding 3 years attended either a consultation with, or a clinic provided by, any doctor in the course of his provision of general medical services, nor

(ii) within the preceding 12 months been offered a consultation pursuant to this sub-paragraph by any doctor,

to participate in a consultation at his practice premises for the purpose of assessing whether he needs to render personal medical services to that patient.

(2) Sub-paragraph (1) shall not apply in the case of a doctor who is a restricted services principal.

(3) When inviting a patient to participate in a consultation pursuant to sub-paragraph (1) a doctor shall comply with the requirements of paragraph 14(3).

(4) Where a patient agrees to participate in a consultation mentioned in sub-paragraph (1), the doctor shall, in the course of that consultation—

(a) where appropriate, seek details from the patient as to his medical history and, so far as may be relevant to the patient’s medical history, as to that of his consanguineous family, in respect of—

(i) illnesses, immunisations, allergies, hereditary diseases, medication and tests carried out for breast or cervical cancer,

(ii) social factors (including employment, housing and family circumstances) which may affect his health,

(iii) factors of his lifestyle (including diet, exercise, use of tobacco, consumption of alcohol, and misuse of drugs or solvents) which may affect his health, and

(iv) the current state of his health;

(b) offer to undertake a physical examination of the patient, comprising—

(i) the measurement of his blood pressure, and

(ii) the taking of a urine sample and its analysis to identify the presence of albumen and glucose, and

(iii) the measurement necessary to detect any changes in his body mass;

(c) record, in the patient’s medical records, his findings arising out of the details supplied by, and any examination of, the patient under this sub-paragraph;

(d) assess whether and, if so, in what manner and to what extent he should render personal medical services to the patient; and

(e) in so far as it would not, in the opinion of the doctor, be likely to cause serious damage to the physical or mental health of the patient to do so, offer to discuss with the patient the conclusions the doctor has drawn as a result of the consultation as to the state of the patient’s health.

(5) In this paragraph “body mass” means the figure produced by dividing the number of kilograms in the patient’s weight by the square of the number of metres in his height.

Patients aged 75 years and over

16.—(1) Subject to sub-paragraph (2), a doctor shall, in addition to and without prejudice to any other obligations under these terms of service, in each period of 12 months beginning on 1st April in each year—

(a) invite each patient on his list who has attained the age of 75 years to participate in a consultation; and

(b) offer to make a domiciliary visit to each such patient,

for the purpose of assessing whether he needs to render personal medical services to that patient.

(2) Sub-paragraph (1) shall not apply in the case of any doctor who is a restricted services principal.

(3) Any consultation pursuant to sub-paragraph (1) may take place in the course of the domiciliary visit pursuant to that sub-paragraph.

(4) In the case of a patient who is accepted by a doctor pursuant to paragraph 6, or assigned to him pursuant to regulation 21 and who has attained the age of 75 years when he is so accepted or assigned, an invitation and an offer pursuant to sub-paragraph (1) shall be made within 12 months of the date of his acceptance or assignment.

(5) A doctor shall, when making an assessment following a consultation under sub-paragraph (1), record in the patient’s medical records the observations made of any matter which appears to him to be affecting the patient’s general health, including, where appropriate the patient's—

(a) sensory functions;

(b) mobility;

(c) mental condition;

(d) physical condition including continence;

(e) social environment;

(f) use of medicines.

(6) A doctor shall keep with the patient’s medical records a report of any observations made in the course of a domiciliary visit made pursuant to sub-paragraph (1) which are relevant to the patient’s general health.

(7) When inviting a patient to participate in a consultation, or offering him a domiciliary visit, pursuant to sub-paragraph (1), a doctor shall comply with the requirements of paragraph 14(3) as if paragraph 14(3) referred to an offer as well as an invitation.

(8) Where a patient has participated in a consultation pursuant to sub-paragraph (1), the doctor shall offer to discuss with him the conclusions he has drawn, as a result of the consultation, as to the state of the patient’s health, unless to do so would, in the opinion of the doctor, be likely to cause serious harm to the physical or mental health of the patient.

17.—(1) Unless prevented by an emergency, a doctor shall attend and treat any patient who attends for the purpose at any place, and during the hours, for the time being approved by the FHSA under paragraph 29, other than a patient who attends when an appointment system is in operation and who has not previously made, and is not then given, an appointment to see the doctor.

(2) In such a case the doctor may refuse to attend and treat the patient during that surgery period, provided that—

(a) the patient’s health would not thereby be jeopardised; and

(b) the patient is offered an appointment to attend again within a time which is reasonable having regard to all the circumstances.

(3) A doctor shall take reasonable steps to ensure that no refusal is made pursuant to sub-paragraph (2) without his knowledge.

Absences, deputies, assistants and partners

18.—(1) Subject to sub-paragraph (2), a doctor is responsible for ensuring the provision for his patients of the services referred to in paragraph 12 throughout each day during which his name is included in the FHSA’s medical list.

(2) A doctor who was, prior to 1st April 1990, relieved by the FHSA of such responsibility in respect of his patients during times approved by the FHSA may continue to enjoy such relief for so long as his name is included in the medical list.

19.—(1) Subject to the following provisions of this paragraph, a doctor shall give treatment personally.

(2) Subject to sub-paragraphs (3), (5) and (6), a doctor (in this sub-paragraph referred to as “the patient’s doctor”) shall be under no obligation to give treatment personally to a patient provided that reasonable steps are taken to ensure the continuity of the patient’s treatment, and in those circumstances treatment may be given—

(a) by another doctor acting as a deputy, whether or not he is a partner or assistant of the patient’s doctor; or

(b) in the case of treatment which it is clinically reasonable in the circumstances to delegate to someone other than a doctor, by a person whom the doctor has authorised and who he is satisfied is competent to carry out such treatment.

(3) Subject to sub-paragraph (4), in the case of maternity medical services a doctor on the obstetric list shall not arrange for the provision of such services by another doctor unless that doctor is a doctor on the obstetric list or satisfies one or more of the criteria set out in Part 1 of Schedule 5.

(4) Sub-paragraph (3) shall not apply where there has been a summons to an obstetric emergency.

(5) In the case of child health surveillance services, a doctor who has, pursuant to regulation 28, undertaken to provide such services shall not arrange for the provision of such services by—

(a) another doctor unless that doctor is included in a child health surveillance list; or

(b) any other person without the consent of the FHSA.

(6) In the case of minor surgery services, a doctor who has, pursuant to regulation 33, undertaken to provide such services shall not arrange for the provision of such services by—

(a) another doctor unless that doctor is included in a minor surgery list; or

(b) any other person.

(7) In this paragraph “a summons to an obstetric emergency” means a summons to the doctor by a midwife or on behalf of the patient to attend when medical attention is required urgently by a woman or her baby during pregnancy, labour or the post-natal period, as defined in regulation 31(7).

20.—(1) In relation to his obligations under these terms of service, a doctor is responsible for all acts and omissions of—

(a) any doctor acting as his deputy;

(b) any deputising service while acting on his behalf; and

(c) any person employed by, or acting on behalf of, him or such a deputy or deputising service,

except where the act or omission is one for which a deputy is responsible under sub-paragraph (2).

(2) Where a doctor whose name is included in the medical list is acting as deputy to another doctor whose name is also included in the list, the deputy is responsible for—

(a) his own acts and omissions in relation to the obligations under these terms of service of the doctor for whom he acts as deputy; and

(b) the acts and omissions of any person employed by him or acting on his behalf.

21.—(1) A doctor shall inform the FHSA of any arrangements for the engagement of a deputy on a regular basis unless the deputy—

(a) is an assistant of the doctor, or is a doctor included in the medical list of an FHSA; and

(b) is to carry out the arrangements at the doctor’s practice premises.

(2) Where a doctor proposes to be absent from his practice for more than a week, he shall inform the FHSA of the name of any doctor responsible for his practice during his absence.

22.—(1) Before entering into arrangements with a deputising service for the provision of any deputy, a doctor shall obtain the consent of the FHSA.

(2) In giving its consent, the FHSA may impose such conditions as it considers necessary or expedient to ensure the adequacy of such arrangements.

(3) Before refusing its consent or imposing any such conditions, the FHSA shall consult the Local Medical Committee.

(4) The FHSA may at any time, and shall periodically, review in consultation with the Local Medical Committee any such consent given or conditions imposed in relation to any doctor under this paragraph, and may withdraw such consent or vary such conditions.

(5) A doctor may appeal to the Secretary of State against refusal of consent or the imposition of a condition under this paragraph or against withdrawal of consent or variation of conditions under this paragraph.

(6) An appeal under sub-paragraph (5) shall be made in writing within 30 days of the decision of the FHSA and shall set out the grounds of appeal.

(7) In determining an appeal under sub-paragraph (5) the Secretary of State may substitute for the FHSA’s decision such decision and conditions as he thinks fit.

23.  A doctor shall take reasonable steps to satisfy himself that a doctor whom he proposes to employ as a deputy or assistant is not disqualified under section 46 of the Act(10) from inclusion in the medical list of the FHSA and he shall not knowingly employ a doctor who is so disqualified.

24.—(1) A doctor shall inform the FHSA of the name of any assistant he employs and of the termination of such employment, and shall not employ any one or more assistants for a total period of more than three months in any period of twelve months without the consent of the FHSA.

(2) The FHSA shall periodically review and may withdraw any consent given, but, before refusing or withdrawing consent, the FHSA shall consult the Local Medical Committee.

(3) The doctor may appeal to the Medical Practices Committee against any refusal or withdrawal of consent.

(4) Any withdrawal of consent under this paragraph shall not have effect until the expiration of a period of one month after the date of notification of the withdrawal, but if the doctor appeals to the Medical Practices Committee against the withdrawal, and the Medical Practices Committee dismisses the appeal, the withdrawal shall not take effect until after such date as that Committee determines being a date falling not less than one month after the date of such dismissal.

25.  A doctor acting as a deputy for another doctor may treat patients at places and at times other than those approved pursuant to paragraph 29 in relation to the doctor for whom he is acting, but when determining the places and times at which he is to provide such treatment, the deputy shall have regard to the convenience of the patients.

26.  When issuing any document under these terms of service a deputy or assistant (other than a partner or assistant whose name is included in the medical list) shall, as well as signing the document himself, enter on it the name of the doctor for whom he is acting, if it does not already appear.

Arrangements at practice premises

27.  A doctor shall—

(a) provide proper and sufficient accommodation at his practice premises, having regard to the circumstances of his practice; and

(b) on receipt of a written request from the FHSA, allow inspection of those premises at a reasonable time by a member or officer of the FHSA or Local Medical Committee or both, authorised by the FHSA for the purpose.

Employees

28.—(1) A doctor shall, before employing any person to assist him in the provision of general medical services, take reasonable care to satisfy himself that the person in question is both suitably qualified and competent to discharge the duties for which he is to be employed.

(2) When considering the competence and suitability of any person for the purpose of sub-paragraph (1), a doctor shall have regard, in particular, to—

(a) that person’s academic and vocational qualifications;

(b) that person’s training and his experience in employment; and

(c) any guidance issued by the FHSA pursuant to regulation 39.

(3) A doctor shall afford to each employee reasonable opportunities to undertake appropriate training with a view to maintaining that employee’s competence.

Doctors' availability to patients

29.—(1) Any doctor whose name is included in a medical list shall—

(a) normally be available at such times and places as shall have been approved by the FHSA or, on appeal, by the Secretary of State in his case, in accordance with the requirements of the following provisions of this paragraph, following an application by the doctor; and

(b) inform his patients about his availability in such manner as the FHSA may require in accordance with sub-paragraph (16).

(2) Subject to sub-paragraphs (3), (4), (5) and (6), the FHSA shall not approve any application submitted by a doctor in relation to the times at which he is to be available unless it is satisfied that—

(a) the times proposed are such that the doctor will normally be available—

(i) in 42 weeks in any period of 12 months,

(ii) for no less than the number of hours in any such week which are specified in the condition imposed or treated as imposed in relation to him under regulation 15, and

(iii) on 5 days in any such week;

(b) the hours for which the doctor will normally be available in any week are to be allocated between the days on which he will normally be available in that week in such a manner as is likely to be convenient to his patients;

(c) where the doctor is a three-quarter-time doctor or a half-time doctor, he is practising in partnership with—

(i) another doctor whose name is included in the medical list and who is himself a full-time doctor, or

(ii) two job-sharing doctors whose names are included in the medical list and whose hours are aggregated for the purpose of head (d) of this sub-paragraph;

(d) where the doctor is a job-sharing doctor—

(i) he is practising in partnership with another doctor whose name is included in the medical list, and

(ii) the hours for which both doctors will normally be available will in aggregate be not less than 26 hours in any week referred to in head (a)(i) of this sub-paragraph.

(3) On any application made pursuant to sub-paragraph (1) by a three-quarter-time doctor or a half-time doctor—

(a) head (a)(iii) of sub-paragraph (2) shall not apply; and

(b) any approval of the application shall be subject to the condition that the approval shall lapse after the expiry of a period of 6 months from that date on which that doctor ceases to satisfy head (c) of sub-paragraph (2).

(4) On any application made pursuant to sub-paragraph (1) by a job-sharing doctor—

(a) head (a)(iii) of sub-paragraph (2) shall apply so as to require either the job-sharing doctor or the other doctor referred to in sub-paragraph (2)(d) to be normally available on each of the days mentioned in that head; and

(b) any approval of the application shall be subject to the condition that the approval shall lapse after the expiry of a period of 6 months from the date on which the doctor ceases to satisfy sub-paragraph (2)(d).

(5) On any application made pursuant to sub-paragraph (1) by a doctor who is a restricted list principal or a restricted services principal, sub-paragraph (2)(a)(i) and (iii), (c) and (d) shall not apply.

(6) The FHSA may, in relation to the application of any full-time doctor who seeks normally to be available on only 4 days in any week referred to in sub-paragraph (2)(a)(i), excuse the doctor from the requirement of head (a)(iii) of that sub-paragraph and approve the application to the extent allowed by paragraph 30.

(7) In this paragraph and in paragraph 30, “available” means, in relation to a doctor, available to provide general medical services to his patients, and for the purposes of calculating the time at which a doctor is to be regarded as available—

(a) account may be taken of any period when the doctor is attending at his practice premises or at any clinic provided by him for his own patients, and of any time spent making a domiciliary visit; but

(b) no account shall be taken of time spent by the doctor holding himself in readiness to make a domiciliary visit if required by any patient;

and “availability” shall be construed accordingly.

(8) An application by a doctor in relation to any place at which he is to be available shall not be approved by the FHSA unless it is satisfied that—

(a) the place at which the doctor proposes to be available is likely to be convenient to his patients;

(b) the location of that place is in accordance with any condition imposed in his case pursuant to section 33(4)(b) or (5) of the Act (distribution of general medical services).

(9) An application for approval pursuant to sub-paragraph (1) shall be made in writing to the FHSA and shall—

(a) include the information specified in Part I of Schedule 8 to these Regulations; and

(b) where appropriate, also include—

(i) in the case of a doctor to whom sub-paragraph (5) applies, the additional information specified in Part II of that Schedule,

(ii) in the case of a doctor to whom sub-paragraph (6) applies, the additional information specified in Part III of that Schedule.

(10) The FHSA shall determine an application within 28 days of receiving it.

(11) In determining any application, the FHSA shall either—

(a) grant approval;

(b) grant approval subject to such conditions as the FHSA sees fit to impose for the purpose of securing that the doctor is available at such times and places as are convenient to his patients; or

(c) refuse approval.

(12) The FHSA shall notify the doctor in writing of its determination, and, where it refuses an application or grants an application subject to conditions, it shall send the doctor a statement in writing of the reasons for its determination and of the doctor’s right of appeal under sub-paragraph (13).

(13) A doctor may within 30 days of receiving a notification pursuant to sub-paragraph (12) appeal in writing to the Secretary of State against any refusal of approval or against any condition imposed pursuant to sub-paragraph (11).

(14) The Secretary of State may, when determining an appeal, either confirm the determination of the FHSA or substitute his own determination for that of the FHSA.

(15) The Secretary of State shall notify the doctor in writing of his determination and shall in every case include with the notification a written statement of the reasons for the determination.

(16) The FHSA may, as it considers appropriate, require a doctor to inform his patients, by displaying a notice at his practice premises or sending notices to them, about the times and places at which he is available.

(17) A doctor may apply to the FHSA for a variation of the times and places at which, in accordance with a determination under this paragraph (“the earlier determination”), he is required to be normally available, and sub-paragraphs (2) to (15) shall apply to the making and determination (“the subsequent determination”) of an application under this sub-paragraph as if it were the first application by that doctor for the purposes of this paragraph.

(18) Where an application made under sub-paragraph (17) is approved or is approved subject to conditions, for the purposes of sub-paragraphs (1) and (16) the earlier determination mentioned in sub-paragraph (17) shall cease to have effect and the subsequent determination mentioned in that sub-paragraph shall have effect instead—

(a) where the subsequent determination is made by the FHSA and no appeal is made, from the day falling 8 weeks after the date on which the doctor receives notification of that FHSA’s determination.

(b) where the subsequent determination is made on appeal, from the day falling 8 weeks after the date on which the doctor receives notification of the Secretary of State’s determination.

(19) Where it appears to the FHSA that a doctor’s hours of availability are allocated for the purposes of sub-paragraph (2)(b) in a manner which may no longer be convenient to his patients, it may, subject to sub-paragraph (26), review the terms of—

(a) any approval granted under sub-paragraph (11)(a) or (b); or

(b) any direction given under sub-paragraph (21)(a);

by the FHSA or the Secretary of State as to such allocation.

(20) On review under sub-paragraph (19) the FHSA shall—

(a) give notice to the doctor of its proposed re-allocation of his hours of availability; and

(b) allow him 30 days within which to make representations to the FHSA about its proposals.

(21) After considering any representations made in accordance with sub-paragraph (20)(b), the FHSA shall either—

(a) direct the doctor to revise the allocation of his hours of availability in the manner specified in the direction; or

(b) confirm that the existing allocation of the doctor’s hours of availability continues to be convenient to his patients.

(22) The FHSA shall notify the doctor in writing of its determination under sub-paragraph (21), and, where it gives a direction under head (a) of that sub-paragraph, it shall include with the notice a statement in writing of the reasons for its determination and of the doctor’s right of appeal under sub-paragraph (23).

(23) A doctor may, within 30 days of receiving notification under sub-paragraph (22), appeal in writing to the Secretary of State against a direction under sub-paragraph (21).

(24) Sub-paragraphs (14) and (15) shall apply to any appeal made under sub-paragraph (23).

(25) A doctor in respect of whom a direction is given under sub-paragraph (21) shall revise the allocation of his hours of availability so as to give effect to the direction—

(a) where the direction is given by the FHSA and no appeal is made, not later than 8 weeks after the date on which he receives notification under sub-paragraph (22); or

(b) where the direction is given or confirmed on appeal, not later than 8 weeks after the date on which he receives notification of the Secretary of State’s decision;

and the allocation of hours as so revised shall be regarded as having been approved for the purposes of sub-paragraphs (1) and (16).

(26) No FHSA shall undertake a review under sub-paragraph (19) on more than one occasion in any period of 2 years.

Doctors available for only 4 days a week

30.—(1) Subject to sub-paragraph (3), where the FHSA is satisfied that, by reason of a doctor’s participation in health-related activities (other than the provision of general medical services to his patients), he would be likely to suffer an unreasonable degree of inconvenience if paragraph 29(2)(a)(iii) applied in his case, it may give its approval for the doctor normally to be available on only 4 days in any week referred to in sub-paragraph (2)(a) of that paragraph.

(2) For the purposes of sub-paragraph (1), “health-related activities” means activities connected with—

(a) the organisation of the medical profession or the training of its members;

(b) the provision of medical care or treatment;

(c) the improvement of the quality of such care and treatment; or

(d) the administration of services under Part I of the Act or of arrangements pursuant to section 29 of the Act for the provision of general medical services,

and in determining whether any activity is a health-related activity, the FHSA shall have regard to the illustrative list in Part IV of Schedule 8.

(3) The FHSA shall not give its approval in accordance with sub-paragraph (1) if, in its opinion—

(a) the effectiveness of the doctor’s services to his patients is likely to be significantly reduced; or

(b) his patients are likely to suffer significant inconvenience,

by reason of the doctor having been relieved from the requirements of paragraph 29(2)(a)(iii).

31.  A doctor who—

(a) intends to operate an appointments system;

(b) succeeds to a practice where such a system is in force; or

(c) joins a partnership operating such a system,

shall notify the FHSA of any appointments system which he proposes to operate or, as the case may be, of any proposal to discontinue such a system.

32.—(1) A doctor shall not, without the consent of the FHSA or, on appeal, the Medical Practices Committee, carry on practice at any house, flat, surgery, branch surgery, or other similar premises (referred to in this paragraph as “the practice premises”) which have been previously occupied or used for the purpose of his practice by another doctor (referred to in this paragraph as “the former occupant”) whose practice has been declared vacant and to whose practice a successor has been, or is to be, appointed; but this provision shall not apply—

(a) where the former occupant or his executors or administrators has or have, in agreement with the FHSA, made an offer to the successor on his appointment to sell or let to him the practice premises upon terms to be approved by the Medical Practices Committee and upon terms that the offer cannot be withdrawn within one month from the date on which the successor was appointed, and the successor has failed or refused to accept the offer before the expiry thereof;

(b) where such an offer was made to the successor and accepted by him before its expiry and the approval of the Medical Practices Committee has been given to the terms of the proposed agreement;

(c) after the expiry of a period of 12 months from the date on which the successor was appointed;

(d) where the former occupant was a member of a partnership and the doctor concerned is another member of the partnership who acquires the practice premises in accordance with the terms of a partnership agreement which has been in operation for a period of 12 months before the date on which notice of the former occupant’s intended retirement was given to the FHSA concerned, or the date of the former occupant’s death; or

(e) where the doctor is using the practice premises in consequence of temporary arrangements for the carrying on of the practice made either under regulation 25 or by agreement between the former occupant or his executors or administrators and the successor pending the approval of the Medical Practices Committee to a proposed sale or lease of the practice premises to the successor.

(2) In this paragraph “successor” means the doctor appointed by the Medical Practices Committee to succeed to the practice in accordance with regulations 13, 14 and 17, and “the date on which the successor was appointed” means—

(a) the date on which the successor is informed that no appeal has been made to the Secretary of State;

(b) in the event of an appeal, the date on which the successor is notified of the Secretary of State’s decision to dismiss the appeal.

33.—(1) Subject to sub-paragraph (2), a doctor shall not, without the consent of the FHSA, or, on appeal, the Medical Practices Committee, start to practise at any house, flat, surgery, branch surgery or other similar premises (referred to in this paragraph as “the practice premises”) within 1 year of their having ceased to be occupied or used for the purpose of his practice by another doctor (referred to in this paragraph as “the former occupant”) who was within one month of such cessation practising at group practice premises as a member of a group, or at accommodation made available by the Secretary of State, less than 3 miles away (in either case) from the practice premises.

(2) Sub-paragraph (1) shall not apply—

(a) where the former occupant gives written consent to another doctor to use the practice premises;

(b) after the former occupant has (or if there was more than one former occupant, all the former occupants have) ceased to practise as a member of a group at the group practice premises, or at accommodation made available by the Secretary of State; or

(c) to any of the former occupants who has ceased to practise at such premises as are mentioned in sub-paragraph (2)(b).

(3) In this paragraph “group practice premises” means premises where practice is wholly or mainly carried on by a group practice.

Practice area

34.—(1) Subject to sub-paragraph (2), a doctor may at any time with the consent of the FHSA, or, on appeal, the Secretary of State, alter the extent of his practice area.

(2) A doctor shall not, contrary to any condition imposed by the Medical Practices Committee, or on appeal the Secretary of State, under section 33(4) or (5) of the Act, open practice premises in any locality or part of a locality where, at the time of his application to open such premises, the Medical Practices Committee is of the opinion that the number of medical practitioners undertaking to provide general medical services in that locality or part of that locality is already adequate.

Notification of change of place of residence

35.  Where a doctor whose name is included in the medical list changes his place of residence he shall notify the FHSA in writing of the change not later than 28 days after such change.

Records

36.  A doctor shall—

(a) keep adequate records of the illnesses and treatment of his patients on forms supplied to him for the purpose by the FHSA; and

(b) forward such records to the FHSA on request as soon as possible; and

within 14 days of being informed by the FHSA of the death of a person on his list and, in any other case of the death of such a person, not later than one month of learning of such a death, forward the records relating to that person to the FHSA.

Certification

37.—(1) A doctor shall issue free of charge to a patient or his personal representatives any medical certificate of a description prescribed in column 1 of Schedule 9, which is reasonably required under or for the purposes of the enactments specified in relation to the certificate in column 2 of that Schedule, except where, for the condition to which the certificate relates, the patient—

(a) is being attended by another doctor (other than a partner, assistant or other deputy of the first named doctor); or

(b) is not being treated by, or under the supervision of, a doctor.

(2) The exception in sub-paragraph (1)(a) shall not apply where the certificate is issued pursuant to regulation 2(1) of the Social Security (Medical Evidence) Regulations 1976(11) (which provides for the issue of a certificate in the form of a special statement by a doctor on the basis of a written report made by another doctor).

(3) Any certificate given under sub-paragraph (1) for the purposes of—

(a) the Social Security Act 1975(12) shall be issued in accordance with any regulations made under that Act(13);

(b) section 17(2) of the Social Security and Housing Benefits Act 1982(14) shall be issued in accordance with any regulations made under that Act(15); or

(c) Part V of, and Schedule 4 to, the Social Security Act 1986(16), shall be issued in accordance with any regulations made under that Act(17).

Fees

38.  A doctor shall not, otherwise than under or by virtue of the Regulations, demand or accept a fee or other remuneration for any treatment, including child health surveillance services, contraceptive services, maternity medical services and minor surgery services, whether under these terms of service or not, which he gives to a person for whose treatment he is responsible under paragraph 4, except—

(a) from any statutory body for services rendered for the purposes of that body’s statutory functions;

(b) from any body, employer or school for a routine medical examination of persons for whose welfare the body, employer or school is responsible, or an examination of such persons for the purpose of advising the body, employer or school of any administrative action they might take;

(c) for treatment which is not of a type usually provided by general medical practitioners and which is given—

(i) pursuant to the provisions of section 65 of the Act, or

(ii) in a registered nursing home which is not providing services under the Act,

if, in either case, the doctor is serving on the staff of a hospital providing services under the Act as a specialist providing treatment of the kind the patient requires and if, within 7 days of giving the treatment, the doctor supplies the FHSA, on a form provided by it for the purpose, with such information about the treatment as it may require;

(d) under section 158 of the Road Traffic Act 1988(18);

(e) from a dentist in respect of the provision at his request of an anaesthetic for a person for whom the dentist is providing general dental services;

(f) when he treats a patient under paragraph 4(3), in which case he shall be entitled to demand and accept a reasonable fee (recoverable in certain circumstances under paragraph 39) for any treatment given, if he gives the patient a receipt on a form supplied by the FHSA;

(g) for attending and examining (but not otherwise treating) a patient at his request at a police station in connection with proceedings which the police are minded to bring against him;

(h) for treatment consisting of an immunisation for which no remuneration is payable by the FHSA in pursuance of the Statement made under regulation 34 and which is requested in connection with travel abroad;

(i) for circumcising a patient for whom such an operation is requested on religious grounds and is not needed on any medical ground;

(j) for prescribing or providing drugs which a patient requires to have in his possession solely in anticipation of the onset of an ailment while he is outside the United Kingdom but for which he is not requiring treatment when the medicine is prescribed;

(k) for a medical examination to enable a decision to be made whether or not it is inadvisable on medical grounds for a person to wear a seat belt;

(l) where the person is not one to whom any of paragraphs (a), (b) or (c) of section 38(1) of the Act(19) applies (including by reason of regulations under section 38(6) of that Act), for testing the sight of that person.

(m) where he is a doctor who is authorised or required by an FHSA under regulation 20 of the Pharmaceutical Regulations to provide drugs, medicines or appliances to a patient and provides for that patient, otherwise than under pharmaceutical services, any Scheduled drug.

39.—(1) Where a person from whom a doctor received a fee under paragraph 38(f) applies to the FHSA for a refund within 14 days of payment of the fee (or such longer period not exceeding a month as the FHSA may allow if it is satisfied that the failure to apply within 14 days was reasonable) and the FHSA is satisfied that the person was on the doctor’s list when the treatment was given, the FHSA may recover the amount of the fee from the doctor, by deduction from his remuneration or otherwise, and shall pay that amount to the person who paid the fee.

(2) Where a doctor has supplied any drug or appliance in respect of which, in the case of a person on his list, he would have been entitled to payment, the FHSA shall credit him with the appropriate amount.

40.  Subject to paragraph 38(f) and (j) a doctor shall not demand or accept a fee or other remuneration from a patient of his for any prescription for any drug or appliance.

41.  A doctor shall not without reasonable excuse demand or accept from the FHSA any fee or other remuneration to which he is not entitled under the provisions of these Regulations, the Statement published under regulation 34 or the Drug Tariff.

42.  A doctor shall take all practicable steps to ensure that any partner, deputy, or assistant of his, whether or not the partner, deputy or assistant is providing general medical services, shall not demand or accept any remuneration for treatment given to the doctor’s patients, or for any prescription for any supply of any drug or appliance for the doctor’s patients, unless the partner, deputy or assistant would have been entitled to charge if the patient had been on his own list.

Prescribing

43.—(1) Subject to paragraph 44, a doctor shall order any drugs or appliances which are needed for the treatment of any patient to whom he is providing treatment under these terms of service by issuing to that patient a prescription form, and such a form shall not be used in any other circumstances.

(2) In issuing any such prescription form the doctor shall himself sign the form in ink with his initials, or forenames, and surname in his own handwriting and not by means of a stamp, and shall so sign only after particulars of the order have been inserted in the form, and—

(a) the prescription shall not refer to any previous prescription; and

(b) a separate prescription form shall be used for each patient, except where a doctor is prescribing in bulk for a school or institution under paragraph 45.

(3) Where a doctor orders drugs specified in Schedule 2 to the Misuse of Drugs Regulations 1985 (20) (controlled drugs to which regulations 14, 15, 16, 18, 19, 20, 21, 23, 25 and 26 of those Regulations apply) for supply by instalments for treating addiction to any drug specified in that Schedule, he shall—

(a) use only the prescription form provided by the FHSA specially for the purposes of supply by instalments;

(b) specify the number of instalments to be dispensed and the interval between each instalment; and

(c) order only such quantity of the drug as will provide treatment for a period not exceeding 14 days.

(4) The form provided by the FHSA specially for the purpose of supply by instalments shall not be used for any purpose other than ordering drugs in accordance with sub-paragraph (3) of this paragraph.

(5) In a case of urgency a doctor may request a chemist to dispense a drug or an appliance before a prescription form is issued, only if—

(a) that drug is not a Scheduled drug;

(b) that drug is not a controlled drug within the meaning of the Misuse of Drugs Act 1971(21), other than a drug which is for the time being specified in Schedule 5 to the Misuse of Drugs Regulations 1985; and

(c) the doctor undertakes to furnish the chemist, within 72 hours, with a prescription form completed in accordance with sub-paragraph (2).

44.—(1) In the course of treating a patient to whom he is providing treatment under these terms of service, a doctor shall not order on a prescription form a drug or other substance specified in Schedule 10 to these Regulations but may otherwise prescribe such a drug or other substance for that patient in the course of that treatment.

(2) In the course of treating such a patient a doctor shall not order on a prescription form a drug specified in an entry in column 1 of Schedule 11 to these Regulations unless—

(a) that patient is a person of a description mentioned in column 2 of that entry;

(b) that drug is prescribed for that patient only for the purpose specified in column 3 of that entry; and

(c) the doctor endorses the face of the form with the reference “SLS”,

but may otherwise prescribe such a drug for that patient in the course of that treatment.

45.—(1) Where a doctor—

(a) is responsible under these terms of service for the treatment of 10 or more persons in a school or other institution in which at least 20 persons normally reside; and

(b) orders, for any two or more of those persons for whose treatment he is responsible, drugs or appliances to which this paragraph applies,

he may use a single prescription form for the purpose.

(2) Where a doctor uses a single prescription form for the purpose mentioned in sub-paragraph (1), he shall (instead of entering on the form the names of the persons for whom the drugs or appliances are ordered) enter on the form—

(a) the name of the institution in which those persons reside; and

(b) the number of persons residing there for whose treatment he is responsible.

(3) This paragraph applies to any drug or appliance which can be supplied as part of pharmaceutical services and which—

(a) in the case of a drug, is not a product of a description or class which is for the time being specified in an order made under section 58(1) of the Medicines Act 1968(22); or

(b) in the case of an appliance, does not contain such a product.

46.  For the purposes of paragraphs 43 and 44 in their application to a doctor who has undertaken to provide contraceptive services, “drugs” includes contraceptive substances and “appliances” includes contraceptive appliances.

Practice leaflet

47.—(1) Subject to paragraph (2), a doctor whose name is included in the medical list of an FHSA shall compile in relation to his practice a document (in this paragraph called a “practice leaflet”) which shall include the information specified in Schedule 12.

(2) Sub-paragraph (1) shall, in relation to a doctor referred to in regulation 4(2)(e), apply only to the extent that the FHSA sees fit.

(3) A doctor shall review his practice leaflet at least once in every period of 12 months, and shall make any amendments necessary to maintain its accuracy.

(4) A doctor shall make available a copy of the most recent edition of his practice leaflet to the FHSA, to each patient on his list and to any other person who, in the doctor’s opinion, reasonably requires one.

(5) A doctor who practises in partnership with other doctors whose names are included in the medical list shall satisfy the requirements of this paragraph if he makes available a practice leaflet, compiled and, where appropriate, revised in accordance with sub-paragraphs (1) and (3), which relates to the partnership as a whole; and in such a case a doctor may, if he so wishes, also produce a practice leaflet relating to his own activities.

Reports to medical officer etc

48.  A doctor shall—

(a) supply in writing to a medical officer within such reasonable period as that officer may specify, any relevant clinical information which he requests about a patient to whom the doctor under these terms of service has issued or has refused to issue a medical certificate; and

(b) answer any inquiries by a medical officer about a prescription form or medical certificate issued by the doctor under these terms of service or about any statement which the doctor has made in a report under these terms of service.

Inquiries about prescriptions and referrals

49.—(1) A doctor whose name is included in the medical list shall, subject to sub-paragraphs (2) and (3) below, sufficiently answer any inquiries, whether oral or in writing, from the FHSA concerning—

(a) any prescription form issued by the doctor under these terms of service;

(b) the considerations by reference to which the doctor issues such forms under these terms of service;

(c) the referral by the doctor under these terms of service of any patient to any other services provided under the Act; and

(d) the considerations by reference to which the doctor refers patients to any such services.

(2) An inquiry referred to in sub-paragraph (1) may be made only for the purpose either of obtaining information to assist the FHSA to discharge its functions or of assisting the doctor in the discharge of his obligations under these terms of service.

(3) A doctor shall not be obliged to answer any inquiry referred to in sub-paragraph (1) unless it is made by a doctor appointed under regulation 38 who produces, on request, written evidence that he is authorised by the FHSA to make such an inquiry on behalf of the FHSA.

Annual reports

50.—(1) A doctor whose name is included in the medical list shall provide annually to the FHSA a report, in accordance with this paragraph, relating to the provision by him of personal medical services (in this paragraph called an “annual report”).

(2) An annual report shall contain the information specified in Schedule 13.

(3) Each annual report shall be compiled in respect of the period of 12 months ending on the 31st March of the year in which it is provided and shall be sent to the FHSA by 30th June of that year.

(4) In the case of a doctor who practises in partnership with other doctors whose names are included in the medical list, the information referred to in sub-paragraph (2) may alternatively be provided in the form of an annual report in respect of the partnership as a whole instead of by each doctor in the partnership individually and in such a case a doctor may, if he so wishes, also produce his own annual report.

(5) Where the FHSA requires that the information referred to in sub-paragraph (2) be provided on a form supplied by the FHSA, the doctor shall use that form.

(6) The FHSA shall not disclose any annual report to any person, unless otherwise lawfully empowered to do so.

Incorporation of provisions of regulations etc.

51.  Any provisions of the following affecting the rights and obligations of doctors shall be deemed to form part of the terms of service—

(a) the Regulations;

(b) so much of Part II of the National Health Service (Service Committees and Tribunal) Regulations 1992(23) as relates to—

(i) the investigation of questions arising between doctors and their patients and other investigations to be made by the medical service committee and the joint services committee and the action which may be taken by the FHSA as a result of such investigations,

(ii) appeals to the Secretary of State from decisions of the FHSA,

(iii) the investigation of cases of alleged excessive prescribing,

(iv) the investigation of certification,

(v) the investigation of record keeping,

(vi) decisions as to treatment for which fees may be charged.

Regulation 5(1)

SCHEDULE 3

PART I INFORMATION AND UNDERTAKINGS TO BE INCLUDED IN AN APPLICATION FOR INCLUSION IN A MEDICAL LIST

1.  Full name.

2.  Sex.

3.  Date of Birth.

4.  Private address and telephone number.

5.  Medical qualifications and where obtained.

6.  Registration number in the Medical Register and date of first registration.

7.  Information about general medical services to be provided for persons in the FHSA’s locality, and in particular whether—

(a) including excluding limited to	maternity medical services
(b) including excluding limited to	contraceptive services
(i) excluding including	fitting of intra-uterine devices
(ii) restricted not restricted	to patients to whom the doctor or partner provides other personal medical services
(c) including excluding limited to	child health surveillance services
(d) including excluding limited to	minor surgery services

8.  Present or most recent appointment.

9.—(a) Name and private address of any intended partner and whether or not the name is in the FHSA’s medical list.

(b) Names and private addresses of members of group (other than those already specified in (a) above) with whom doctor intends to practise.

10.  Whether applied/intending to apply for inclusion in obstetric list/child health surveillance list/minor surgery list.

11.  Notification of the geographical boundary of the applicant’s proposed practice area by reference to a sketch, diagram or plan.

12.  Notification of address(es) of proposed practice premises.

13.  Whether the applicant intends to practise as—

(a) a full-time doctor;

(b) a three-quarter-time doctor;

(c) a half-time doctor;

(d) a job-sharing doctor; or

(e) a restricted doctor.

14.  Where the applicant intends to practise as a job-sharing doctor, the name of the other job-sharing doctor with whose hours the applicant’s hours are to be aggregated for the purposes of regulation 15(1)(d).

15.  Notification of proposed days and hours of attendance.

16.  Telephone number(s) at which prepared to receive messages.

17.  Undertaking that if accepting as a patient a person who, at the time of acceptance, is residing at a place outside the practice area, he will visit him at that address.

18.  Proposed place of residence (including telephone number and distance from main practice premises) and an undertaking to inform the FHSA whenever changing permanent residence.

19.  Declaration that he is a registered medical practitioner, included in the Medical Register in that name.

20.  Undertaking to be bound by the terms of service.

Regulation 5(2)

PART II INFORMATION AND UNDERTAKINGS TO BE INCLUDED IN AN APPLICATION TO FILL A VACANCY

1.  Full name.

2.  Sex.

3.  Date of birth.

4.  Private Address and telephone number.

5.  Medical qualifications and where obtained.

6.  Declaration that he is a registered medical practitioner, included in the Medical Register in that name.

7.  Registration number in the Medical Register and date of first registration.

8.  Whether applying to succeed to a practice, or be appointed to a vacancy in a practice.

9.  Notification of the geographical boundary of the applicant’s proposed practice area by reference to a sketch, diagram or plan.

10.  Notification of address(es) of proposed practice premises.

11.  Whether the applicant intends to practise as—

(a) a full-time doctor;

(b) a three-quarter-time doctor;

(c) a half-time doctor;

(d) a job-sharing doctor; or

(e) a restricted doctor.

12.  Where the applicant intends to practise as a job-sharing doctor, the name of the other job-sharing doctor with whose hours the applicant’s hours are to be aggregated for the purposes of regulation 15(1)(d).

13.  Notification of proposed days and hours of attendance.

14.  Telephone number(s) at which prepared to receive messages.

15.  Undertaking that if accepting as a patient a person who at the time of acceptance or succession is residing at a place outside the practice area he will visit him at that address.

16.  Proposed place of residence (including telephone number and distance from main surgery) and an undertaking to inform the FHSA whenever changing permanent residence.

17.  Whether or not on the medical list for the FHSA’s locality.

18.  If not in the FHSA’s medical list, present or most recent appointment, and if in general practice, whether as principal, assistant or locum.

19.  Professional experience (including starting and finishing dates of each appointment) separated into:

(a) trainee or assistant experience in general practice;

(b) general practice experience;

(c) hospital appointments;

(d) other (including obstetric) experience;

(e) any additional supporting particulars.

20.  The name and address of principal to whom trainee or assistant.

21.  Particulars of covenants restricting medical practice by the applicant in the FHSA’s locality.

22.  Name and address of any intended partner and whether or not the name is included in the FHSA’s medical list.

23.  Names and addresses of two referees.

24.  If applicant is not in the FHSA’s medical list—

(1) name of any other FHSA in whose list he is included;

(2) particulars of any outstanding application for inclusion on the medical list of any FHSA;

(3) information about general medical services to be provided and, in particular, whether—

(a) including excluding	maternity medical services limited to
(b) including excluding limited to	contraceptive services
(i) excluding including	fitting of intra-uterine including devices
(ii) restricted not restricted	to patients to whom the doctor or partner provides other personal medical services
(c) including excluding limited to	child health surveillance services
(d) including excluding limited to	minor surgery services

(4) whether or not applied/intending to apply for—

(a) inclusion in minor surgery list,

(b) inclusion in child health surveillance list,

(c) inclusion in obstetric list; and

(5) undertaking to be bound by terms of service.

Regulation 5(3)

PART IIIA INFORMATION TO BE INCLUDED IN REPORT BY FHSA TO MEDICAL PRACTICES COMMITTEE IN RESPECT OF APPLICATION FOR INCLUSION IN A MEDICAL LIST

1.  Full name of applicant.

2.  Copies of—

(a) the applicant’s application to the FHSA;

(b) any evidence concerning the applicant’s qualifications and experience produced in accordance with the National Health Service (Vocational Training) Regulations 1979(24); and

(c) any declaration of partnership.

3.  Date from which applicant proposes to provide general medical services and whether he proposes to practise as a full-time, three-quarter-time, half-time, job-share or restricted doctor.

4.  Area of the FHSA’s locality in which such services are to be provided.

5.  The number of doctors who are not restricted doctors already providing general medical services in that area whose names are included in the FHSA’s medical list and whether they are full-time, three-quarter-time, half-time, job-sharers, and the number of full-time assistants.

6.  The total number of patients registered with the medical list doctors as at 31st March, 30th June, 30th September or 31st December, whichever is the last to precede the date of the report.

7.  The average number of patients on the lists of doctors providing general medical services in that area.

8.  Where the applicant proposes to provide such services in partnership with another doctor, details of each proposed partner, as respects—

(a) his full name and his age, and whether he practises as a full-time, three-quarter-time, half-time, job-sharer or restricted doctor;

(b) the total number of patients on his list;

(c) the number of patients on his list who are over the age of 65;

(d) the number of patients on his list who attract deprivation payments;

(e) where the proposed partner is a doctor who is authorised or required to provide drugs, medicines or appliances, the number of patients on his list who are patients in respect of whom he is so authorised;

(f) the total annual number of temporary resident attendances based on the last available four complete quarters;

(g) the total number of rural practice units credited for the last known quarter;

(h) the number of hours in each week which he devotes to health-related activities, within the meaning of paragraph 30 of Schedule 2;

(i) the number and location of the practice premises from which he provides general medical services and sessions spent at branch surgeries.

9.  Details of each doctor, including where requested, the sex of that doctor who provides general medical services from practice premises situated up to 5 miles from the applicant’s proposed practice premises, as respects each of the matters mentioned in sub-paragraphs (a) to (h) of paragraph 8 above.

10.  Any other information which the FHSA considers to be relevant to the determination of the application.

11.  Whether or not the application is supported by the FHSA, including details of its reasons for supporting or not supporting the application and any report from the Local Medical Committee or Community Health Council.

12.  If the Medical Practices Committee so request, a breakdown of the lists of patients by reference to age and/or sex and a description of the area.

13.  A statement that the FHSA has confirmed that the applicant is a registered medical practitioner and that his name as entered on the application is currently included in the Medical Register.

14.  A statement that the applicant is a British or a European Community national or, if not, that the FHSA has checked that the applicant is entitled to work as a self-employed practitioner in the United Kingdom.

Regulation 5(4)

PART IIIB INFORMATION TO BE INCLUDED IN REPORT BY ADDITIONAL FHSAS TO MEDICAL PRACTICES COMMITTEES IN RESPECT OF APPLICATION FOR INCLUSION IN A MEDICAL LIST

1.  Full name of applicant.

2.  Date from which the applicant proposes to provide medical services.

3.  The area of the FHSA’s locality in which medical services are to be provided.

4.  The name of any other FHSA in whose locality the applicant provides or intends to provide medical services.

5.  The area of any other FHSA’s locality in which the applicant provides, or intends to provide, medical services.

6.  Details of the distance from the nearest point on the FHSA boundary (to whom the current application is made) to:—

(a) the doctor’s nearest surgery,

(b) the doctor’s private address.

7.  Whether the areas named in the application—

(a) are/are not within the catchment area of the doctor’s present practice,

(b) are/are not adjacent to the doctor’s area of practice,

(c) do/do not already contain patients of the doctor’s present partnership practice.

8.  Whether local practices are unwilling/unable to accept the proposed patients.

9.  Whether the applicant intends to open a branch surgery.

10.  Whether or not the application is supported by the FHSA, including details of its reasons for supporting or not supporting the application and any report from the Local Medical Committee or Community Health Council.

11.  Any other information which the FHSA considers to be relevant to the determination of the application, including whether or not it is the opinion of the FHSA that the doctor would be able to comply with the terms of service.

Regulation 5(5)

PART IIIC INFORMATION TO BE INCLUDED IN REPORT BY FHSA TO MEDICAL PRACTICES COMMITTEE IN RESPECT OF A RESTRICTED LIST APPLICATION

1.  Full name of applicant.

2.  Date from which applicant proposes to provide general medical services.

3.  Copy of the applicant’s application to the FHSA.

4.  Copy of evidence concerning the applicant’s qualifications and experience produced in accordance with the National Health Service (Vocational Training) Regulations 1979(25).

5.  The name of the establishment or organisation, to which patients connected to them, the applicant will be limiting the provision of general medical services, and the numbers of such patients.

6.  The area of the FHSA’s locality in which the establishment or organisation is sited.

7.  A statement that the FHSA has confirmed that the applicant is a registered medical practitioner and that his name as entered on the application is currently included in the Medical Register.

8.  A statement that the applicant is a British or European Community national or, if not, that the FHSA has checked that the applicant is entitled to work as a self-employed practitioner in the United Kingdom.

9.  Whether the application is in respect of a new practice or an extension of the doctor’s current practice.

10.  Whether the application is made by the successor to any other doctor and if so the name of that doctor.

11.  Whether or not the application is supported by the FHSA, including details of its reasons for supporting or not supporting the application and any report from the Local Medical Committee or Community Health Council.

12.  Any other information which the FHSA considers to be relevant to the determination of the application.

Regulation 5(6)

PART IIID INFORMATION TO BE INCLUDED IN A REPORT BY FHSA TO MEDICAL COMMITTEE IN RESPECT OF A RESTRICTED SERVICES APPLICATION

1.  Full name of applicant.

2.  Copy of the applicant’s application to the FHSA.

3.  The names of any proposed partners and/or members of the applicant’s group practice.

4.  Copy of any declaration of partnership, or intent to practise in association with a group practice.

5.  The date from which the applicant proposes to provide the services in question.

6.  Confirmation that the applicant is eligible to be included in the child health surveillance list or the minor surgery list as the case may be.

7.  The area of the FHSA’s locality in which the medical services in question are to be provided.

8.  The name of any other FHSA in whose locality the applicant provides or intends to provide the medical services.

9.  The area of any other FHSA’s locality in which the applicant provides, or intends to provide, the medical services.

10.  Whether or not the application is supported by the FHSA, including details of its reasons for supporting or not supporting the application and any report from the Local Medical Committee or Community Health Council.

11.  A statement that the FHSA has confirmed that the applicant is a registered medical practitioner and that his name as entered on the application is currently included in the medical register.

12.  A statement that the applicant is a British or European Community national, or, if not, that the FHSA has checked that the applicant is entitled to work as a self-employed practitioner in the United Kingdom.

13.  Any other information which the FHSA considers to be relevant to the determination of the application, including any unusual factors that may affect demand for the particular services in question.

14.  If the Medical Practices Committee so request, details of the numbers of doctors on the Medical List already providing the services in question in the area of locality of the FHSA where the applicant proposes to provide the service.

Regulation 11(1)

PART IV INFORMATION TO BE INCLUDED IN A REPORT BY FHSA TO THE MEDICAL PRACTICES COMMITTEE CONCERNING ADEQUACY OF SERVICES

1.  The names of the doctors in the medical list providing general medical services mainly in the FHSA’s locality.

2.  The names and numbers of full-time assistants.

3.  Where appropriate, the serial number of each partnership.

4.  The part of the FHSA’s locality where the doctors mainly practise, and whether each doctor practises as—

(a) a full-time doctor;

(b) a three-quarter time doctor;

(c) a half-time doctor; or

(d) a job-sharing doctor.

5.  In respect of each doctor,—

(a) his full name, sex and date of birth;

(b) his index number;

(c) the number of patients on his list in respect of each FHSA in whose medical list he is included and the total.

Regulation 11(2)

PART V INFORMATION TO BE INCLUDED IN A REPORT BY FHSA ON DEATH, WITHDRAWAL OR REMOVAL OF DOCTOR FROM MEDICAL LIST

1.—(a) the full name, age, practice address and, if requested, the sex of the doctor and the area of the FHSA’s locality in which such services were provided and the date of his death, withdrawal or removal from the medical list;

(b) whether the doctor practised as—

(i) a full time doctor,

(ii) a three-quarter time doctor,

(iii) a half-time doctor,

(iv) a job-sharing doctor,

(v) a restricted doctor;

(c) the total number of patients on his list;

(d) the number of patients on his list who are over the age of 65;

(e) where he was a doctor who was authorised or required under regulation 20 of the Pharmaceutical Regulations to provide drugs or appliances, the number of patients on his list in respect of whom he was so authorised;

(f) the total annual number of temporary resident attendances based on the last available four complete quarters;

(g) the number of patients on his list attracting deprivation payments;

(h) the number of hours per week which he devoted to health related activities within the meaning of paragraph 30 of Schedule 2;

(i) the total number of rural practice units credited for the last known quarter;

(j) the number and location of the practice premises from which he provided general medical services, and sessions spent at branch surgeries;

(k) in respect of a single handed doctor, whether the premises are available for sale or rent.

2.  Where the doctor provided services in partnership with another doctor, details of each partner as respects each of the matters mentioned in paragraph 1(a)–(j) above.

3.  Details of each doctor who provides general medical services from practice premises situated up to 5 miles from the doctors' practice premises as respects each of the matters mentioned in paragraph 1(a)–(j).

4.  Any other information which the FHSA considers to be relevant.

5.  The number of doctors who are not restricted doctors providing general medical services in the area where the doctor practised whose names are included in the FHSA’s medical list and whether they are full-time, three-quarter-time, half-time or job-sharers, and the number of full-time assistants.

6.  If the Medical Practice Committee so request a breakdown of age/sex of patient lists and type of area of residence.

7.  A recommendation from the FHSA, with reasons, for dealing with the vacancy, giving an account of any report from the Local Medical Committees or Community Health Council (if made); and in respect of partnerships the proposals by the remaining partner(s).

Regulation 16(2)

PART VI INFORMATION TO BE INCLUDED IN AN APPLICATION FOR THE VARIATION OF A CONDITION IMPOSED IN CONNECTION WITH INCLUSION IN A MEDICAL LIST

1.  Full name.

2.  Private address.

3.  Information about the services to be provided, and in particular whether they—

(a) will include will exclude will be limited to	maternity medical services
(b) will include will exclude will be limited to	contraceptive services
(i) excluding including	fitting of intra-uterine including devices
(ii) restricted not restricted	to patients to whom the doctor or partner provides other personal medical services
(c) will include will exclude will be limited to	child health surveillance services
(d) will include will exclude will be limited to	minor surgery services

4.  Name and private address(es) of partner(s) with whom the applicant intends to practise, indicating whether or not the name is in the FHSA’s medical list.

5.  Details of any proposed changes to—

(a) the geographical boundary of the applicant’s practice area, by reference to a sketch, diagram or plan;

(b) his practice premises;

(c) his place of residence; or

(d) his telephone number(s) at which messages may be received.

6.  Where applicant is seeking a variation of a condition relating to his hours or the sharing of work, whether he wishes to practise as —

(a) a full-time doctor;

(b) a three-quarter-time doctor;

(c) a half-time doctor;

(d) a job-sharing doctor and the name of the other job-sharing doctor with whose hours the applicant’s hours are to be aggregated for the purposes of regulation 15(1)(d); or

(e) a restricted doctor.

Regulation 19(2)

PART VII INFORMATION TO BE SUPPLIED BY FHSA WITH REGARD TO DOCTORS' LISTS

1.  The number of patients included on the doctor’s list, in each of the age groups in accordance with the capitation fee they attract.

2.  The number of children included on the doctor’s list for whom he or she has undertaken to provide child health surveillance services.

3.  The number of patients included on the doctor’s list for whom a deprivation payment is due, in each group in accordance with the level of fee they attract.

4.  The number of patients included for whom a rural practice payment is due.

5.  The number of patients for whom the doctor has assumed responsibility from a doctor who is relieved of the responsibility to provide out of hours services.

Regulation 27(3)

PART VIII INFORMATION TO BE SUPPLIED BY DOCTOR APPLYING FOR INCLUSION IN A CHILD HEALTH SURVEILLANCE LIST

1.  Full name.

2.  Address of practice premises.

3.  Registration number in the Medical Register and date of first registration.

4.  Details of relevant medical experience after date of first registration (and, if appropriate, before that date) during last 5 years, together with any references.

5.  Title of any post-graduate qualification held and date awarded.

Regulation 32(3)

PART IX INFORMATION TO BE SUPPLIED BY DOCTOR APPLYING FOR INCLUSION IN A MINOR SURGERY LIST

1.  Name.

2.  Address of practice premises.

3.  Registration number in the Medical Register and date of first registration.

4.  Details of relevant medical experience after date of first registration (and, if appropriate, before that date) during last 5 years together with any references.

5.  Details of premises and equipment to be used.

6.  Title of any post-graduate qualification held and date awarded.

Regulation 30(3)

PART X INFORMATION TO BE SUPPLIED BY DOCTOR APPLYING FORINCLUSION IN AN OBSTETRIC LIST

1.  Name.

2.  Address of practice premises.

3.  Registration number in the Medical Register and date of first registration.

4.  Details of relevant obstetric experience during the previous 10 years (and, if appropriate, before that date), together with any references.

5.  Details of relevant training undertaken during the previous 5 years.

6.  Title of any relevant post-graduate qualification held and date awarded.

Regulations 2(1) and 28

SCHEDULE 4 CHILD HEALTH SURVEILLANCE SERVICES

1.  The services referred to in regulation 28(2)(a) shall comprise—

(a) the monitoring—

(i) by the consideration of information concerning the child received by or on behalf of the doctor, and

(ii) on any occasion when the child is examined or observed by or on behalf of the doctor (whether pursuant to sub-paragraph (b) or otherwise),

of the health, well-being and physical, mental and social development (all of which characteristics are referred to in this Schedule as “development”) of the child while under the age of 5 years with a view to detecting any deviations from normal development;

(b) the examination of the child by or on behalf of the doctor on so many occasions and at such intervals as shall have been agreed between the FHSA and the health authority in whose district the child resides (in this Schedule called “the relevant health authority”) for the purposes of the provision of child health surveillance services generally in that district.

2.  The records mentioned in regulation 28(3)(b) shall comprise an accurate record of—

(a) the development of the child while under the age of 5 years, compiled as soon as is reasonably practicable following the first examination mentioned in paragraph 1(a) and, where appropriate, amended following each subsequent examination mentioned in that sub-paragraph; and

(b) the responses (if any) to offers made to the child’s parent for the child to undergo any examination referred to in paragraph 1(b).

3.  The information mentioned in regulation 28(3)(c) shall comprise—

(a) a statement, to be prepared and dispatched to the relevant health authority as soon as is reasonably practicable following any examination referred to in paragraph 1(a), of the procedures undertaken in the course of that examination and of the doctor’s findings in relation to each such procedure;

(b) such further information regarding the development of the child while under the age of 5 years as the relevant health authority may request.

Regulation 30

SCHEDULE 5

PART I CRITERIA TO BE CONSIDERED BEFORE INCLUSION IN AN OBSTETRIC LIST

1.  Whether the applicant has, within the period of 10 years previous to the date of his application, held, for not less than 6 months, a resident appointment in a maternity unit in a hospital or hospitals in a member state of the European Community during which at least half the time has been spent on obstetric work.

2.  Where an applicant has held an appointment of the type mentioned in paragraph 1 during a period ending more than 9 years, 6 months previous to the date of his application, whether he has, within the period of 5 years previous to the date of his application, either—

(a) attended a refresher course in obstetrics of not less than one week; or

(b) spent not less than 2 weeks as an obstetric officer in a maternity unit under the supervision of a consultant obstetrician.

3.  Whether the applicant has, within the period of 2 years previous to the date of his application—

(a) been included in the obstetric list of the same or another FHSA; and

(b) at the time of ceasing to be included in that obstetric list, was qualified for admission to it under paragraph 1 or 2.

4.  Whether the applicant has, in the period of 5 years previous to the date of his application, been engaged in obstetric practice involving—

(a) attendance at not less than 100 maternity cases involving responsibility for ante-natal care; and

(b) attendance at not less than 50 cases involving the supervision of labour and responsibility for the post-natal period.

5.  Whether the applicant is, at the time of the application, in the obstetric list of another FHSA.

6.  Whether the applicant has, in the period of 2 years previous to the date of his application, had at least 6 months consecutive training experience under the supervision of a consultant obstetrician in a maternity unit involving attendances at—

(a) not less than 20 normal deliveries;

(b) not less than 10 abnormal deliveries; and

(c) not less than 10 ante-natal and 2 post-natal clinics.

7.  For the purposes of this Part of this Schedule—

“maternity unit” means a hospital or that part of a hospital which specialises in the provision of care to a woman during her pregnancy, labour and the post-natal period;

“refresher course in obstetrics” means a course of study in obstetrics approved by the Regional Adviser on Post-Graduate Education, or in Wales, by the Postgraduate Dean;

“normal delivery” means a delivery of a baby which does not require active intervention by a doctor;

“abnormal delivery” means a delivery of a baby which does require active intervention by a doctor;

“ante-natal clinic” means a clinic where a woman’s pregnancy is monitored by or on behalf of a doctor and appropriate care provided;

“post-natal clinic” means a clinic where an assessment is made by a doctor of the health of a woman following the post-natal period and where the post-natal examination is performed and appropriate care given;

“resident appointment” means a post in a hospital requiring the post-holder to reside at the hospital at times when required for duty at the hospital;

“obstetric officer” means a doctor undertaking post-graduate training in obstetrics in a hospital under the supervision of a consultant obstetrician;

“obstetric practice” means the use of the skills required of a doctor supervising and caring for a woman’s health during her pregnancy, labour and the post-natal period;

“consultant obstetrician” means a doctor engaged by a hospital or hospitals as a consultant in the specialty of obstetrics.

Regulation 31

PART II MATERNITY MEDICAL SERVICES

1.  A doctor with whom a woman has made an arrangement under regulation 31(2) for the provision of maternity medical services during the ante-natal period shall take all reasonable steps to secure that she receives all necessary personal medical services connected with the pregnancy from the time when the arrangement is made until—

(a) where the pregnancy is terminated by miscarriage, the woman has received all necessary personal medical services in connection with the miscarriage; or

(b) where the woman goes into labour, the date of the onset of that labour.

2.  A doctor with whom a woman has made an arrangement under regulation 31(2) for the provision of maternity medical services during labour shall take all reasonable steps to secure that she receives all necessary personal medical services during that labour.

3.  A doctor with whom a woman has made an arrangement under regulation 31(2) for the provision of maternity medical services during the post-natal period shall—

(a) take all reasonable steps to secure that the woman receives all necessary personal medical services related to the recent pregnancy or labour during the post-natal period; and

(b) where the pregnancy has resulted in the birth of a live baby, render all necessary personal medical services to that baby during the period of 14 days following its birth, unless, during that period, another doctor has accepted the baby for inclusion in his list pursuant to an application made on the baby’s behalf under regulation 20(1).

4.  A doctor with whom a woman has made an arrangement under regulation 31(2) for the provision of a post-natal examination shall, not less than 6 weeks nor more than 12 weeks after the conclusion of her pregnancy—

(a) undertake a full post-natal examination of the woman; and

(b) take all reasonable steps to ensure that the woman is informed of the need for any further treatment she may require.

5.  Where the doctor is aware that an arrangement under regulation 31(2) is about to be terminated under regulation 31(5) he shall take all reasonable steps to ensure that the woman is informed of the manner in which she may make a further such arrangement with another doctor.

6.  The doctor shall be relieved of his obligations under paragraph 1, 2, 3 or 4, as the case may be,

(a) during any period when the woman is outside the doctor’s practice area and is not present at any other place where, pursuant to paragraph 13 of the terms of service, the doctor is obliged to visit and treat her;

(b) where it is proposed that the woman’s labour should take place in a hospital, to the extent that responsibility for her care has been taken over by the hospital; and

(c) where the woman has been admitted to a hospital as an in-patient, to the extent that her care has been taken over by the hospital.

Regulations 2(1) and 33

SCHEDULE 6 MINOR SURGERY PROCEDURES

Injections	intra articular peri articular varicose veins haemorrhoid
Aspirations	joints cysts bursae hydrocele
Incisions	abcesses cysts thrombosed piles
Excisions	sebaceous cysts lipoma skin lesions for histology intradermal naevi, papilloma, dermatofibroma and similar conditions warts removal of toe nails (partial and complete)
Curette cautery and cryocautery	warts and verrucae other skin lesions (eg molluscum contagiosum)
Other	removal of foreign bodies nasal cautery

Regulation 18

SCHEDULE 7 FORM OF CERTIFICATE TO BE ISSUED BY THE MEDICAL PRACTICES COMMITTEE UNDER PARAGRAPH 1(3) OF SCHEDULE 10 TO THE NATIONAL HEALTH SERVICE ACT 1977

Regulation 3(2) Schedule 2 paragraph 29

SCHEDULE 8 DOCTORS' HOURS

PART I INFORMATION TO BE INCLUDED WITH ANY APPLICATION UNDER PARAGRAPH 29 OF SCHEDULE 2

1.  The address of the proposed practice premises.

2.  The days in each week during which the doctor will normally be in attendance at the practice premises and available for consultation by his patients.

3.  The hours of each such attendance by the doctor.

4.  The hours of any attendance by the doctor on those occasions when he is not usually available to provide the full range of services specified in paragraph 12 of the terms of service (for example, for providing emergency treatment only).

5.  The frequency, duration and purpose of any clinic provided by the doctor.

6.  The estimated total time each week to be spent making any domiciliary visits.

7.  The doctor’s proposals for notifying patients of the times and places approved by the FHSA.

8.  The terms of any condition imposed by the Medical Practices Committee or the Secretary of State under section 33(4)(b) or (5) of the Act.

9.  In the case of a doctor to whom paragraph 18(2) of the terms of service does not apply, his proposals for discharging his continuous responsibility for his patients.

PART II ADDITIONAL INFORMATION TO BE INCLUDED IN ANY APPLICATION BY A DOCTOR WHO IS A RESTRICTED SERVICES PRINCIPAL OR A RESTRICTED LIST PRINCIPAL

1.  In the case of a restricted services principal—

(a) the proposed allocation of the total number of hours for which he is normally to be available in any week between each category of services provided; and

(b) where different services are to be provided at different places, the place at which each category of services is to be provided.

2.  In the case of a restricted list principal, the name, address and nature of the establishment(s) or organisation(s) with which his patients are connected.

PART III ADDITIONAL INFORMATION TO BE INCLUDED IN ANY APPLICATION BY A DOCTOR WHO SEEKS NORMALLY TO BE AVAILABLE ON ONLY 4 DAYS IN EACH WEEK

1.  A brief description of each health-related activity with reference to which the application is made.

2.  The days in each week during which the doctor will be undertaking that activity.

3.  The number of hours in each week which are likely to be occupied in the course of such activity.

PART IV ILLUSTRATIVE LIST OF HEALTH-RELATED ACTIVITIES

• Appointments concerning medical education or training.

• Medical appointments within the health service other than in relation to the provision of general medical services.

• Medical appointments under the Crown, with Government Departments or Agencies, or public or local authorities.

• Appointments concerning the regulation of the medical profession or the Medical Practices Committee.

paragraph 37

SCHEDULE 9 LIST OF PRESCRIBED MEDICAL CERTIFICATES

Column 1	Column 2
Description of Medical Certificate	Short title of enactment under or for the purpose of which certificate required
1.  To support a claim or to obtain payment either personally or by proxy; to prove inability to work or incapacity for self-support for the purposes of an award by the Secretary of State; or to enable proxy to draw pensions etc. }	Naval and Marine Pay and Pensions Act 1865(26)
	Air Force (Constitution) Act 1917(27)
	Pensions (Navy, Army, Air Force and Mercantile Marine) Act 1939(28)
	Personal Injuries (Emergency Provisions) Act 1939(29)
	Pensions (Mercantile Marine) Act 1942(30)
	Polish Resettlement Act 1947(31)
	Home Guard Act 1951(32)
	Social Security Act 1975(33)
	Industrial Injuries and Diseases (Old Cases) Act 1975(34)
	Parts I and III of the Social Security and Housing Benefits Act 1982(35)
	Part II of, and Part V of, and Schedule 4 to, the Social Security Act 1986(36)
2.  To establish pregnancy for the purpose of obtaining welfare foods	Section 13 of the Social Security Act 1988(37)
3.  To establish fitness to receive inhalational analgesia in childbirth	Nurses, Midwives and Health Visitors Act 1979(38)
4.  To secure registration of still-birth	Births and Deaths Registration Act 1953(39)
5.  To enable payment to be made to an institution or other person in case of mental disorder of persons entitled to payment from public funds	Section 142 of the Mental Health Act 1983(40)
6.  To establish unfitness for jury service	Juries Act 1974(41)
7.  To establish unfitness to attend for medical examination	National Service Act 1948(42)
8.  To support late application for reinstatement in civil employment or notification of non-availability to take up employment, owing to sickness }	Reinstatement in Civil Employment Act 1944(43)
	Reinstatement in Civil Employment Act 1950(44)
	Reserve Forces Act 1980(45)
9.  To enable a person to be registered as an absent voter on grounds of physical incapacity.	Representation of the People Act 1983
10.  To support application for certificates conferring exemption from charges in respect of drugs, medicines and appliances.	National Health Service Act 1977
11.  To support a claim by or on behalf of a severely mentally impaired person for exemption from liability to pay the community charge.	Local Government Finance Act 1988

SCHEDULE 10 DRUGS AND OTHER SUBSTANCES NOT TO BE PRESCRIBED FOR SUPPLY UNDER PHARMACEUTICAL SERVICES

• 10. 10 Cleaning and Disinfecting Solution

• 10. 10 Rinsing and Neutralising Solution

• 10 Day Slimmer Tablets

• 10 Hour Capsules

• 4711 Cologne

• Abidec Capsules

• Acarosan Foam

• Acarosan Moist Powder

• Acnaveen Bar

• Acne Aid Bar

• Actal Suspension

• Actal Tablets

• Actifed Compound Linctus

• Actifed Expectorant

• Actifed Linctus with Codeine

• Actifed Syrup

• Actifed Tablets

• Actomite

• Actonorm Gel

• Actonorm Powder

• Actonorm Tablets

• Actron Tablets

• Adult Cough Balsam (Cupal)

• Adult Meltus Cough and Catarrh Linctus

• Adult Tonic Mixture (Thornton and Ross)

• Afrazine Nasal Drops

• Afrazine Nasal Spray

• Afrazine Paediatric Nasal Drops

• Agarol Emulsion

• Agiolax Granules

• Airbal Breathe Easy Vapour Inhaler

• AL Tablets

• Alagbin Tablets

• Alcin Tablets

• Aletres Cordial (Potters)

• Alexitol Sodium Suspension 360 mg/5 ml

• Alexitol Sodium Tablets

• Algipan Tablets

• Alka-Donna Suspension

• Alka-Donna Tablets

• Alka-Donna P Mixture

• Alka-Donna P Tablets

• Alka Mints

• Alka-Seltzer Tablets

• Alket Powders

• All Fours Cough Mixture (Harwood)

• All Fours Mixture (Glynwed Wholesale Chemists)

• All Fours Mixture (Roberts Laboratories)

• Allbee with C Capsules

• Allbee with C Elixir

• Almasilate Tablets 500 mg

• Almazine Tablets 1 mg

• Almazine Tablets 2.5 mg

• Almay Aftersun Soother

• Almay Face Powder

• Aloin Tablets 40 mg

• Alophen Pills

• Alpine Tea

• Alprazolam Tablets 0.25 mg

• Alprazolam Tablets 0.5 mg

• Alprazolam Tablets 1 mg

• Altacaps

• Altacite Suspension

• Altacite Plus Tablets

• Altacite Tablets

• Altelave Liquid

• Aludrox Gel

• Aludrox Suspension

• Aludrox MH Suspension

• Aludrox SA Suspension

• Aludrox Tablets

• Aluhyde Tablets

• Aluminium Hydroxide and Silicone Suspension

• Aluminium Phosphate Gel

• Aluminium Phosphate Tablets 400 mg

• Alupent Expectorant Mixture

• Alupent Expectorant Tablets

• Aluphos Gel

• Aluphos Tablets

• Alupram Tablets 2 mg

• Alupram Tablets 5 mg

• Alupram Tablets 10 mg

• Aluzyme Tablets

• Alzed Tablets

• AMI-10 Rinsing and Storage Solution

• Amiclear Contact Lens Cleanser Tablets

• Amidose Saline Solution 30 ml

• Amin-Aid

• Amisyn Tablets

• Ammonia and Ipecacuanha Mixture BP

• Ammonium Chloride and Morphine Mixture BP

• Amplex Mouthwash

• Amplex Mint Capsules

• Amplex Original Capsules

• Anadin Analgesic Capsules Maximum Strength

• Anadin Analgesic Tablets

• Anadin Extra Analgesic Tablets

• Anadin Paracetamol Tablets

• Anadin Tablets Soluble

• Andrews Liver Salts Effervescent Powder

• Andrews Liver Salts (Diabetic Formula) Effervescent Powder

• Andursil Liquid

• Andursil Tablets

• Anestan Bronchial Tablets

• Aneurone Mixture

• Angiers Junior Aspirin Tablets

• Angiers Junior Paracetamol Tablets

• Anorvit Tablets

• Antasil Liquid

• Antasil Tablets

• Antistin-Privine Nasal Drops

• Antistin-Privine Nasal Spray

• Antitussive Linctus (Cox)

• Antoin Tablets

• Antussin Liquid (Sterling Winthrop)

• Anxon Capsules 15 mg

• Anxon Capsules 30 mg

• Anxon Capsules 45 mg

• Aperient Tablets (Brome and Schimmer)

• Aperient Tablets (Kerbina)

• Apodorm Tablets 2.5 mg

• Apodorm Tablets 5 mg

• APP Stomach Powder

• APP Stomach Tablets

• Arocin Capsules

• Ascorbef Tablets

• Ascorbic Acid and Hesperidin Capsules (Regent Laboratories)

• Asilone Orange Tablets

• Asilone Tablets

• Askit Powders

• Askit Tablets

• Aspergum Chewing Gum Tablets 227 mg

• Aspirin Chewing-Gum Tablets 227 mg

• Aspirin Tablets, Effervescent Soluble 300 mg

• Aspirin Tablets, Effervescent Soluble 500 mg

• Aspirin Tablets, Slow (Micro-Encapsulated) 648 mg

• Aspro Clear Extra Tablets

• Aspro Clear Tablets

• Aspro Extra Strength Tablets 500 mg

• Aspro Junior Tablets

• Aspro Microfined Tablets

• Aspro Paraclear Tablets

• Aspro Paraclear Junior Tablets

• Asthma Tablets (Cathay)

• Astroplast Analgesic Capsules

• Atensine Tablets 2 mg

• Atensine Tablets 5 mg

• Atensine Tablets 10 mg

• Ativan Tablets 1 mg

• Ativan Tablets 2.5 mg

• Atrixo

• Aveeno Bar

• Aveeno Bar Oilated

• Aveeno Baby

• Aveenobar

• Ayrtons Macleans Formula Tablets

• B Complex Capsules (Rodale)

• B Complex Super Capsules (Rodale)

• B Extra Tablets (British Chemotherapeutic Products)

• Babezone Syrup

• Baby Chest Rub Ointment (Cupal)

• Babylix Syrup

• Babysafe Tablets

• Badedas Bath Gelee

• Balm of Gilead (Robinsons)

• Balm of Gilead Cough Mixture (Wicker Herbal Stores)

• Balm of Gilead Liquid (Culpeper)

• Balm of Gilead Mixture (Potters)

• Banfi Hungarian Hair Tonic

• Banimax Tablets

• Barker’s Liquid of Life Solution

• Barker’s Liquid of Life Tablets

• Barkoff Cough Syrup

• Barnes-Hind Cleaning and Soaking Solution

• Barnes-Hind Intensive Cleaner

• Barnes-Hind No. 4 Cleaner

• Barnes-Hind Wetting and Soaking Solution

• Bausch and Lomb Cleaning Tablets

• Bausch and Lomb Daily Lens Cleaner

• Bausch and Lomb Saline Solution

• Bayer Aspirin Tablets 300 mg

• BC500 Tablets

• BC500 with Iron Tablets

• BC500 Vitamin Sachets Effervescent

• Becosym Forte Tablets

• Becosym Syrup

• Becosym Tablets

• Becotab Tablets

• Beecham CoughCaps

• Beechams Day Nurse Capsules

• Beechams Day Nurse Syrup

• Beechams Catarrh Capsules

• Beechams Night Nurse Capsules

• Beechams Night Nurse Syrup

• Beechams Pills

• Beechams Powders

• Beechams Powders Capsule Form

• Beechams Powders Mentholated

• Beechams Powders Tablet Form

• Beehive Balsam

• Bekovit Tablets

• Belladonna and Ephedrine Mixture, Paediatric, BPC

• Bellocarb Tablets

• Benadon Tablets 20 mg

• Benadon Tablets 50 mg

• Benafed Linctus

• Benerva Compound Tablets

• Benerva Injection 25 mg/ml

• Benerva Injection 100 mg/ml

• Benerva Tablets 3 mg

• Benerva Tablets 10 mg

• Benerva Tablets 25 mg

• Benerva Tablets 50 mg

• Benerva Tablets 100 mg

• Benerva Tablets 300 mg

• Bengers Food

• Bengue’s Balsam

• Benylin Chesty Cough Linctus

• Benylin Children’s Cough Linctus

• Benylin Day and Night Cold Treatment

• Benylin Decongestant Linctus

• Benylin Dry Cough Linctus

• Benylin Expectorant

• Benylin Fortified Linctus

• Benylin Mentholated Cough and Decongestant Linctus

• Benylin Paediatric

• Benylin with Codeine

• Benzedrex Inhaler

• Benzoin Inhalation BP

• Bepro Cough Syrup

• Bergasol Ultra Protection Tanning Lotion

• Best Royal Jelly Capsules

• Biactol Anti-Bacterial Face Wash

• Bile Beans Formula 1 Pill

• Biocare GLA Complex Tablets

• Biocare Efaplex Linseed/GLA Blend Capsules

• Bioflavonoid C Capsules

• Bioscal Hair Formula

• Bio-Strath Drops

• Bio-Strath Elixir

• Biovital Vitamin Tonic

• Biovital Tablets

• Birley’s Antacid Powder

• Bis-Mag Lozenges

• Bis-Peps Tablets

• Bisma-Calna Cream

• Bisma-Rex Powder

• Bisma-Rex Tablets

• Bismag Antacid Powder

• Bismag Tablets

• Bismuth Compound Lozenges BPC

• Bismuth Dyspepsia Lozenges

• Bismuth Pepsin and Pancreatin Tablets

• Bismuth, Soda and Pepsin Mixture

• Bisodol Antacid Powder

• Bisodol Extra Tablets

• Bisodol Tablets

• Bisolvomycin Capsules

• Bisolvon Elixir

• Bisolvon Tablets

• Blackcurrant Cough Elixir (Thornton and Ross)

• Blackcurrant Syrup Compound (Beben)

• Blandax Suspension

• Blavig Tablets

• Blood Tonic Mixture (Thompsons)

• Boldolaxine Tablets

• Bonemeal Calfos, Vit A Ester, Vit D Tablets

• Bonomint Chewing Gum

• Bonomint Tablets

• Booth’s Cough and Catarrh Elixir

• Boots Baby Oil

• Boots Cold Relief Powder for Solution

• Boots Compound Laxative Syrup of Figs

• Boots Cough Relief for Adults

• Boots Glycerin and Blackcurrant Soothing Cough Relief

• Boots Hard Lens Soaking Solution

• Boots Hard Lens Wetting Solution

• Boots Health Salts

• Boots Indigestion Plus Mixture

• Boots Indigestion Powder

• Boots No. 7 Vitamin E Skin Cream

• Boots Orange Drink

• Boots Soft Lens Comfort Solution

• Boots Soft Lens Soaking Solution

• Boots Soya Milk

• Boots Vapour Rub Ointment

• Boston Lens Cleaning Solution

• Boston Lens Wetting and Soaking Solution

• Box’s Balm of Gilead Cough Mixture

• Bravit Capsules

• Bravit Tablets

• Breoprin Tablets 648 mg

• Brewers Yeast Tablets (3M Health Care)

• Brewers Yeast-Super B Tablets (Rodale)

• Brewers Yeast Tablets (Phillips Yeast Products)

• Bricanyl Compound Tablets

• Bricanyl Expectorant

• Brogans Cough Mixture

• Brogans Cough Syrup

• Bromazepam Tablets 1.5 mg

• Bromazepam Tablets 3 mg

• Bromazepam Tablets 6 mg

• Bromhexine Hydrochloride Elixir 4 mg/5 ml

• Bromhexine Hydrochloride Tablets 8 mg

• Bronalin Expectorant

• Bronalin Paediatric Cough Syrup

• Bronchial and Cough Mixture (Worthington Walter)

• Bronchial Balsam (Cox)

• Bronchial Catarrh Syrup (Rusco)

• Bronchial Cough Mixture (Evans Medical)

• Bronchial Emulsion (Three Flasks) (Thornton and Ross)

• Bronchial Emulsion AS Extra Strong (Ayrton Saunders)

• Bronchial Mixture (Rusco)

• Bronchial Mixture Extra Strong (Cox)

• Bronchial Mixture Sure Shield Brand

• Bronchial Tablets (Leoren)

• Bronchialis Mist Liquid (Industrial Pharmaceutical Services)

• Bronchialis Mist Nig Double Strength (Phillip Harris Medical)

• Bronchisan Childrens Cough Syrup

• Bronchisan Cough Syrup

• Broncholia Mixture

• Bronchotone Solution

• Bronkure Cough and Bronchitis Mixture (Jacksons)

• Brontus Syrup

• Brontus Syrup for Children

• Brontussin Cough Suppressant Mixture

• Brooklax Tablets

• Brotizolam Tablets 0.125 mg

• Brotizolam Tablets 0.25 mg

• Bufferin Tablets

• Buttercup Baby Cough Linctus

• Buttercup Syrup

• Buttercup Syrup Honey and Lemon

• Cabdrivers Adult Linctus

• Cabdrivers Diabetic Linctus

• Cabdrivers Nasal Decongestant Tablets

• Cadbury’s Coffee Compliment

• Cafadol Tablets

• Caffeine and Dextrose Tablets

• Calamage

• Calcimax Syrup

• Calcinate Tablets

• Calcium Syrup (Berk Pharmaceuticals)

• California Syrup of Figs

• Calpol Six Plus Suspension

• Calpol Tablets

• Calsalettes Sugar Coated Tablets

• Calsalettes Uncoated Tablets

• Camfortix Linctus P1

• Canderel Intense Sweetner Spoonful

• Cantaflour

• Capramin Tablets

• Carbellon Tablets

• Carisoma Compound Tablets

• Carnation Coffeemate

• Carnation Instant Build-Up

• Carnation Slender Meal Replacement (A11 Flavours)

• Carrzone Powder

• Carters Little Pills

• Cascara Evacuant Liquid Mixture

• Cascara Tablets BP

• Castellan No. 10 Cough Mixture

• Catarrh and Bronchial Syrup (Thornton and Ross)

• Catarrh Cough Syrup (Boots)

• Catarrh-Ex Tablets

• Catarrh Mixture (Herbal Laboratories)

• Catarrh Syrup for Children (Boots)

• Catarrh Tablets (Cathay)

• Ce-Cobalin Syrup

• Ceeyees Tablets

• Celaton Rejuvenation Tablets

• Celaton CH3 Strong and Calm Tablets

• Celaton CH3 Triplus Tablets

• Celaton CH3 + Ease and Vitality Tablets

• Celaton Whole Wheat Germ Capsules

• Celavit 1 Powder

• Celavit 2 Powder

• Celavit 3 Powder

• Celevac Granules

• Centrax Tablets 10mg

• Cephos Powders

• Cephos Tablets

• Charabs Tablets

• Charvita Tablets

• Cheroline Cough Linctus

• Cherry Bark Cough Syrup Children’s (Loveridge)

• Cherry Bark Linctus Adults (Loveridge)

• Cherry Cough Balsam (Herbal Laboratories)

• Cherry Cough Linctus (Savory and Moore)

• Cherry Cough Mixture (Rusco)

• Cherry Flavoured Extract of Malt (Distillers)

• Chest and Cough Tablets (Brome and Schimmer)

• Chest and Cough Tablets (Kerbina)

• Chest and Throat Tablets No. 8,000 (English Grains)

• Chest Pills (Brome and Schimmer)

• Chest Tablets (Kerbina)

• Chesty Cough Syrup (Scott and Bowne)

• Chilblain Tablets (Boots)

• Child’s Cherry Flavoured Linctus (Cupal)

• Children’s Blackcurrant Cough Syrup (Rusco)

• Children’s Cherry Cough Syrup (Thornton and Ross)

• Children’s Cough Linctus (Ransoms)

• Children’s Cough Mixture (Beecham)

• Children’s Cough Mixture (Loveridge)

• Children’s Cough Syrup (Ayrton Saunders)

• Children’s Cough Syrup (Cox)

• Children’s Cough Syrup (Evans Medical)

• Children’s Cough Syrup (Thornbers)

• Children’s Medicine Liquid (Hall's)

• Children’s Phensic Tablets

• Children’s Wild Cherry Cough Linctus (Evans Medical)

• Chilvax Tablets

• Christy’s Rich Lanolin

• Christy’s Skin Emulsion

• Chocolate Laxative Tablets (Isola)

• Chocovite Tablets

• Cidal

• Cidex Longlife

• Cidex Sterilising Solution

• Cinnamon Essence Medicinal Mixture (Langdale)

• Cinnamon Tablets Medicinal (Langdale)

• Cinota Drops

• Citrosan Powder

• Claradin Effervescent Tablets

• Clarkes Blood Mixture

• Clean and Soak

• Cleansing Herb Dried (Potters)

• Cleansing Herbs (Brome and Schimmer)

• Cleansing Herbs Powder (Dorwest)

• Clerz Lubricating and Rewetting Eye Drops

• Clorazepate Dipotassium Capsules 7.5mg

• Clorazepate Dipotassium Capsules 15mg

• Clorazepate Dipotassium Tablets 15mg

• Co-op Aspirin Tablets BP 300mg

• Co-op Bronchial Mixture

• Co-op Halibut Liver Oil Capsules BP

• Co-op Paracetamol Tablets BP 500mg

• Co-op Soluble Aspirin Tablets BP 300mg

• Cobalin H Injection 250 mcg/ml

• Cobalin H Injection 1000 mcg/ml

• Cobalin Injection 100 mcg/ml

• Cobalin Injection 250 mcg/ml

• Cobalin Injection 500 mcg/ml

• Cobalin Injection 1000 mcg/ml

• Coda-Med Tablets

• Cod Liver Oil and Creosote Capsules (5 Oval) (R P Scherer)

• Cod Liver Oil and Creosote Capsules (10 Oval) (R P Scherer)

• Cod Liver Oil Caps 10 Minims (Woodward)

• Cod Liver Oil High Potency Capsules (R P Scherer)

• Cod Liver Oil with Malt Extract and Hypophosphite Syrup (Distillers)

• Cod Liver Oil 0.3ml Capsules (R P Scherer)

• Cod Liver Oil 0.6ml Capsules (R P Scherer)

• Codalax

• Codalax Forte

• Codanin Analgesic Tablets

• Codis Soluble Tablets

• Codural Tablets

• Cojene Tablets

• Cold and Influenza Capsules (Regent Laboratories)

• Cold and Influenza Mixture (Boots)

• Cold and Influenza Mixture (Davidson)

• Cold and Influenza Mixture (Rusco)

• Cold and Influenza Mixture (Thornton and Ross)

• Cold Relief (Blackcurrant Flavour) Granular Powder (Boots)

• Cold Relief Capsules (Scott and Bowne)

• Cold Relief Tablets (Boots)

• Cold Tablets (Roberts)

• Coldrex Powder

• Coldrex Tablets

• Colgard Emergency Essence (Lane Health Products)

• Colgate Dental Cream with MFP Fluoride

• Colgate Disclosing Tablets

• Collins Elixir

• Colocynth and Jalap Tablets Compound BPC 1963

• Colocynth Compound Pills BPC 1963

• Cologel Liquid

• Communion Wafers

• Complan

• Comploment Continus Tablets

• Compound Fig Elixir BP

• Compound Rhubarb Oral Powder BP

• Compound Rhubarb Tincture BP

• Compound Syrup of Glycerophosphates BPC 1963

• Compound Syrup of Hypophosphites BPC 1963

• Comtrex Capsules

• Comtrex Liquid

• Comtrex Tablets

• Concavit Capsules

• Concavit Drops

• Concavit Injection

• Concavit Syrup

• Congreves Balsamic Elixir

• Constipation Herb Dried (Potters)

• Constipation Herbs (Hall's)

• Constipation Herbs (Mixed Herbs) (Brome and Schimmer)

• Constipation Mixture No. 105 (Potters)

• Contac 400 Capsules

• Contactaclean Cleaning Solution

• Contactasoak Disinfecting and Soaking Solution

• Contactasol 02 Care Solution

• Contactasol Complete Care All-In-One Solution

• Contactasol Wetting Solution

• Copholco Cough Syrup

• Copholcoids

• Coppertone Apres Plage Aftersun Milk

• Corrective Tablets (Ayrton Saunders)

• Correctol Tablets

• Cosalgesic Tablets

• Cosylan Syrup

• Coterpin Syrup

• Cough and Bronchitis Mixture (Davidson)

• Cough and Cold Mixture (Beecham)

• Cough Balsam (Abernethy's)

• Cough Balsam (Thornbers)

• Cough Expectorant Elixir (Regent Laboratories)

• Cough Linctus (Sanderson's)

• Cough Linctus Alcoholic (Thomas Guest)

• Cough Linctus for Children (Boots)

• Cough Medicine for Infants and Children Solution (Boots)

• Cough Mixture (Tingles)

• Cough Mixture Adults (Thornton and Ross)

• Cough Mixture Adults (Wicker Herbal Stores)

• Cough Syrup Best (Diopharm)

• Cough Tablets (Kerbina)

• Country Basket Rice Cakes

• Covermark Removing Cream

• Covonia Bronchial Balsam Linctus

• Cow and Gate Babymeals Stage One

• Cow and Gate Baby Milk Plus

• Cow and Gate Premium Baby Food

• Cox Pain Tablets

• Crampex Tablets

• Cranberry Juice

• Cream of Magnesia Tablets 300 mg

• Cremaffin Emulsion

• Creosote Bronchial Mixture (Loveridge)

• Crookes One-a-Day Multivitamins with Iron

• Crookes One-a-Day Multivitamins without Iron

• Croupline Cough Syrup (Roberts)

• Cupal Health Salts

• Cupal Nail Bite Lotion

• Cupanol Over Six Paracetamol Suspension

• Cuticura Medicated Foam Bath

• Cuticura Talcum Powder

• Cyanocobalamin Solution (any strength)

• Cyanocobalamin Tablets (any strength)

• Cytacon Liquid

• Cytacon Tablets

• Cytamen 250 Injection

• Cytamen 1000 Injection

• Dakin’s Golden Vitamin Malt Syrup

• Dalivit Capsules

• Dalivit Syrup

• Dalmane Capsules 15 mg

• Dalmane Capsules 30 mg

• Dansac Skin Lotion

• Davenol Linctus

• Daxaids Tablets

• Day-Vits Multivitamin and Mineral Tablets

• Dayovite

• De Witt’s Analgesic Pills

• De Witt’s Antacid Powder

• De Witt’s Antacid Tablets

• De Witt’s Baby Cough Syrup

• De Witt’s Cough Syrup

• De Witt’s PL Pills

• Deakin and Hughes Cough and Cold Healer Mixture

• Deakin’s Fever and Inflammation Remedy Mixture

• Delax Emulsion

• Delimon

• Deltasoralen Bath Lotion

• Dentakit Toothache First Aid Kit

• Derbac Soap

• Dermacolor Cleansing Cream

• Dermacolor Cleansing Lotion

• Dermacolor Cleansing Milk

• Desiccated Liver Tablets

• Desiccated Liver USNF Tablets

• Detox Tablets (Hursdrex)

• Dextrogesic Tablets

• Dextromethorphan Hydrobromide Solution 3.75 mg/5 ml

• Dextromethorphan Hydrobromide Solution 7.5 mg/5 ml

• Dextromethorphan Hydrobromide Syrup 6.6 mg/5 ml

• Dextromethorphan Hydrobromide Syrup 13.5 mg/5 ml

• Dextropropoxyphene and Paracetamol Dispersible Tablets

• Dextropropoxyphene and Paracetamol Soluble Tablets

• DF 118 Elixir

• DF 118 Injection

• DF 118 Tablets

• DGL 1 Suspension

• DGL 2 Suspension

• DGT 1 Tablets

• DGT 2 Tablets

• Diabetic Bronal Syrup

• Dialar Forte Syrup 5 mg/5 ml

• Dialar Syrup 2 mg/5 ml

• Dialume Capsules 500 mg

• Diazepam Capsules, Slow 10 mg

• Diazepam Elixir 5 mg/5ml

• Dietade Diabetic Jam

• Dietade Diabetic Marmalade

• Dietade Diabetic Squash

• Dietade Fruit Sugar

• Dietade Jelly Crystals

• Digesprin Antacid Tablets

• Digestells Lozenges

• Dihydroxyaluminium Sodium Carbonate Tablets

• Dijex Liquid

• Dijex Tablets

• Dimotane Expectorant

• Dimotane Expectorant DC

• Dimotane with Codeine Elixir

• Dimotane with Codeine Paediatric Elixir

• Dimotapp Elixir

• Dimotapp Elixir Paediatric

• Dimotapp LA Tablets

• Dimotapp P Tablets

• Dimyril Linctus

• Dinnefords Gripe Mixture

• Disprin Extra Tablets

• Disprin Solmin Tablets

• Disprin Tablets

• Disprinex Tablets

• Disprol Tablets

• Distalgesic Soluble Tablets

• Distalgesic Tablets

• Do-Do Linctus

• Do-Do Tablets

• Dolasan Tablets

• Doloxene Capsules

• Doloxene Compound Pulvules

• Dolvan Tablets

• Dorbanex Capsules

• Dorbanex Liquid

• Dorbanex Liquid Forte

• Dormonoct Tablets 1 mg

• Dr Brandreth’s Pills

• Dr D E Jongh’s Cod Liver Oil with Malt Extract and Vitamins Fortified Syrup

• Dr William’s Pink Pills

• Drastin Tablets

• Dristan Decongestant Tablets with Antihistamine

• Dristan Nasal Spray

• Droxalin Tablets

• Dry Cough Linctus (Scott and Bowne)

• Dual-Lax Extra Strong Tablets

• Dual-Lax Tablets

• Dulca Tablets

• Dulcodos Tablets

• Dulco-Lax Suppositories

• Dulco-Lax Tablets

• Duo-Gastritis Mixture (Baldwin's)

• Duphalac Syrup

• Duralin Capsules Extra Strength

• Duralin Tablets

• Duttons Cough Mixture

• Dynese Aqueous Suspension

• Dynese Tablets

• D001 Capsules

• D002 Capsules

• D004 Capsules

• D006 Capsules

• D007 Capsules

• D009 Capsules

• D010 Capsules

• D011 Capsules

• D012 Capsules

• D013 Capsules

• D014 Capsules

• D017 Capsules

• D018 Capsules

• D019 Capsules

• D020 Capsules

• D021 Capsules

• D024 Capsules

• D029 Capsules

• D030 Capsules

• D031 Capsules

• D032 Capsules

• D033 Capsules

• D034 Capsules

• D036 Capsules

• Ecdilyn Syrup

• Educol Tablets

• Efamol

• Efamol Capsules

• Efamol Marine Capsules

• Efamol Oil

• Efamol Plus Capsules

• Efamol PMP

• Efamolia Night Cream

• Effer-C Tablets

• Effico Syrup

• Eldermint Cough Mixture (Herbal Laboratories)

• Elgydium Toothpaste

• Elizabeth Arden Flawless Finish

• Elizabeth Arden Sunblock Cream Factor 15

• Elizabeth Arden Sunscience Superblock Cream SPF 34

• Elkamol Tablets

• Emulave

• Emuwash

• Endet Powders

• Ener-G Gluten-free and Soya-free Macaroon Cookies

• Ener-G Gluten-free Rice Peanut-Butter Cookies

• Ener-G Gluten-free Rice Walnut Cookies

• Ener-G Low-Protein and Gluten-free Egg Replacer

• Energen Starch Reduced Crispbread

• Engran HP Tablets

• Engran Tablets

• Eno Fruit Salts

• EP Tablets

• EPOC Capsules

• Equagesic Tablets

• Eskornade Spansule Capsules

• Eskornade Syrup

• Eso-Col Cold Treatment Tablets

• Euhypnos Capsules 10mg

• Euhypnos Elixir 10mg/5ml

• Euhypnos Forte Capsules 20mg

• Evacalm Tablets 2mg

• Evacalm Tablets 5mg

• Evans Cough Balsam

• Evening Primrose Oil

• Evening Primrose Oil Capsules

• Evident Disclosing Cream

• Ex-Lax Chocolate Laxative Tablets

• Ex-Lax Pills

• Expectorant Cough Mixtures (Beecham)

• Expulin Cough Linctus

• Expulin Paediatric Cough Linctus

• Expurhin Paediatric Decongestant

• Extil Compound Linctus

• Extravite Tablets

• Extren Tablets

• Exyphen Elixir

• E001 Capsules

• E015 Capsules

• E018 Capsules

• E021 Capsules

• E031 Capsules

• E032 Capsules

• Fabrol Granules

• Fade Out Skin Lightening Cream

• Fairy Household Liquid

• Falcodyl Linctus

• Falkamin

• Fam Lax Tablets

• Famel Expectorant

• Famel Linctus

• Famel Original Linctus

• Family Cherry Flavoured Linctus (Cupal)

• Family Herbal Pills

• Farex Fingers

• Farleys Rusks

• Father Pierre’s Monastery Herbs

• Fe-Cap C Capsules

• Feac Tablets

• Feen-a-Mint Tablets

• Fefol-Vit Spansules

• Femerital Tablets

• Feminax Tablets

• Fendamin Tablets

• Fennings Adult Cooling Powders

• Fennings Children’s Cooling Powders

• Fennings Little Healers Pills

• Fennings Mixture

• Fennings Soluble Junior Aspirin Tablets

• Fenox Nasal Drops

• Fenox Nasal Spray

• Ferfolic Tablets

• Fergluvite Tablets

• Ferraplex B Tablets

• Ferrlecit Tablets/Dragees

• Ferrograd C Tablets

• Ferrol

• Ferrol Compound Mixture

• Ferromyn B Elixir

• Ferromyn B Tablets

• Ferrous Gluconate Compound Tablets

• Fesovit Spansules

• Fesovit Z Spansules

• Fibre Biscuits

• Fine Fare Aspirin Tablets 300mg

• Fine Fare Hot Lemon Powders

• Flar Capsules

• Flavelix Syrup

• Flexcare Soft Lens Solution

• Flexsol Solution

• Flora Margarine

• Floradix Formula Liquid

• Floradix Tablets

• Floral Arbour Tablets (Cathay)

• Flucaps

• Flunitrazepam Tablets 1mg

• Fluralar Capsules 15mg

• Fluralar Capsules 30mg

• Flurazepam Capsules 15mg

• Flurazepam Capsules 30mg

• Flurazepam Hydrochloride Capsules 15mg

• Flurazepam Hydrochloride Capsules 30mg

• Flu-Rex Tablets

• Flurex Bedtime Cold Remedy

• Flurex Capsules

• Flurex Decongestant Inhalant Capsules

• Flurex Hot Lemon Concentrate

• Flurex Tablets

• Folped

• Formulix

• Forprin Tablets

• Fortagesic Tablets

• Fortison Low Sodium

• Fortral Capsules 50mg

• Fortral Injection

• Fortral Suppositories

• Fortral Tablets 25mg

• Fortral Tablets 50mg

• Fortris Solution

• Fosfor Syrup

• Franol Expectorant

• Franolyn Sed Liquid

• Frisium Capsules 5mg

• Frisium Capsules 10mg

• Frisium Capsules 20mg

• Fybranta Tablets

• Fynnon Calcium Aspirin Tablets

• Fynnon Salt

• G Brand Linctus

• Galake Tablets

• Gale’s Honey

• Galfer-Vit Capsules

• Galloway’s Baby Cough Linctus

• Galloway’s Bronchial Cough Care

• Galloway’s Bronchial Expectorant

• Galloway’s Cough Syrup

• Gamophen

• Gastalar Tablets

• Gastric Ulcer Tablets No.1001

• Gastrils Pastilles

• Gastritabs

• Gastrovite Tablets

• Gatinar Syrup

• Gaviscon Granules

• Gelusil Lac Powder

• Gelusil Tablets

• Genasprin Tablets

• Genatosan

• Gentian Acid Mixture with Nux Vomica

• Gentian Alkaline Mixture with Nux Vomica

• Gentian and Rhubarb Mixture BPC

• Georges Vapour Rub Ointment

• Geriplex Capsules

• Gevral Capsules

• Gevral Tablets

• GF Brand Baking Powder

• GF Brand Banana Cake

• GF Brand Chocolate Nut Cookies

• GF Brand Cooking Crumbs

• GF Brand Date and Walnut Cake

• GF Brand English Style Mustard

• GF Brand Fruit Bran Biscuits

• GF Brand Ginger Cake

• GF Brand Ginger Cookies

• GF Brand Gluten-free Coconut Cookies

• GF Brand Gluten-free Maize Biscuits with Chocolate

• GF Brand Gluten-free Maize Biscuits with Hazelnut

• GF Brand Gluten-free Pastry Mix

• GF Brand Gluten-free Thin Wafer Bread

• GF Brand Gravy Mix

• GF Brand Hot Breakfast Cereal

• GF Brand Lemon Cake

• GF Brand Muesli

• GF Brand Muesli Fruit Biscuits

• GF Dietary Low Protein Pizza Mix with Tomato Topping Mix and Baking Dish

• GF Dietary Low Protein Vegetable Burgers in Low Protein Sauce

• GF Dietary Low Protein Vegetable Casserole

• Givitol Capsules

• Gladlax Tablets

• Glemony Balsam (Baldwin's)

• Glenco Elixir

• Gluca-Seltzer Effervescent Powder

• Glucodin

• Glycerin Honey and Lemon Cough Mixture (Isola)

• Glycerin Honey and Lemon Linctus (Boots)

• Glycerin Honey and Lemon Linctus with Ipecacuanha (Boots)

• Glycerin Lemon and Honey and Ipecacuanha (Thomas Guest)

• Glycerin Lemon and Honey Linctus (Rusco)

• Glycerin Lemon and Honey Syrup (Cupal)

• Glycerin Lemon and Honey Syrup (Thomas Guest)

• Glycerin Lemon and Honey Syrup (Waterhouse)

• Glycerin Lemon and Ipecacuanha Cough Mixture (Isola)

• Glykola Elixir

• Glykola Infants Elixir

• Goat’s Milk Spray Dried Powder

• Golden Age Vitamin and Mineral Capsules

• Golden Health Tablets (Kerbina)

• Golden Health Tablets (Brome and Schimmer)

• Gon Tablets

• Gonfalcon Tablets

• Grangewood Insomnia Tablets

• Granogen

• Granose Liquid Soya Milk

• Granoton Emulsion

• Gregovite C Tablets

• GS Tablets

• Guaiphenesin Syrup (any strength)

• Guanor Expectorant

• H-Pantoten Tablets

• Hactos Chest and Cough Mixture (Thomas Hubert)

• Halaurant Syrup

• Halcion Tablets 0·125mg

• Halcion Tablets 0·25mg

• Haliborange Syrup

• Haliborange Tablets

• Halibut Liver Oil A and D Capsules (Rodale)

• Halin Tablets

• Halocaps Inhalant Capsules

• Halycitrol Emulsion

• Hayphryn Nasal Spray

• Head and Shoulders Shampoo

• Health Salts (Wicker Herbal Stores)

• Health Tonic Mixture (Hall's)

• Healtheries Rice Crispbread

• Healthilife Sunflower Seed Oil Capsules 500mg

• Heart Shape Indigestion Tablets

• Hedamol Capsules

• Hedex Plus Capsules

• Hedex Seltzer Granules

• Hedex Soluble Granules

• Hedex Tablets

• Heinz Weight Watcher Baked Beans

• Hemingways Catarrh Syrup

• Hemoplex Injection

• Hepacon B12 Injection

• Hepacon Liver Extract Injection

• Hepacon-Plex

• Hepacon B-Forte Injection

• Hepanorm Tablets

• Herbal Aperient Tablets (Cathay)

• Herbal Aperient Tablets (Kerbina)

• Herbal Bronchial Cough Tablets (English Grains)

• Herbal Laxative Naturtabs

• Herbal Pile Tablets

• Herbal Quiet Nite Sleep Naturtabs

• Herbal Syrup (Baldwin's)

• Herbalene Herbs

• Hermesetas (blue)

• Hermesetas Gold

• Hermesetas Light

• Hermesetas Liquid Sweetener

• Hermesetas Sprinkle Sweet

• Hexidin Solution

• Hi-g-ah Tea

• Hi-pro Liver Tablets

• Hill’s Adult Balsam

• Hill’s Junior Balsam

• Hip C Rose Hip Syrup

• Histalix Expectorant

• Honey and Molasses Cough Mixture (Lane Health Products)

• Hot Blackcurrant Cold Remedy (Beechams)

• Hot Lemon Cold Remedy (Beechams)

• Hot Lemon Cold Treatment (Scott and Bowne)

• Hot Measure Solution (Reckitt and Colman)

• Hydrocare Boiling/Rinsing Solution

• Hydrocare Cleaning and Soaking Solution

• Hydrocare Preserved Saline Solution

• Hydrocare Protein Remover Tablets

• Hydroclean Solution

• Hydron Europe Cleaning Solution

• Hydron Europe Comfort Soaking Solution

• Hydron Europe Solusal

• Hydron Europe Solution Comfort

• Hydrosoak Disinfecting and Soaking Solution

• Hydrosol Comfort Solution

• Hypon Tablets

• Iberet 500 Tablets

• Iberol Tablets

• ICC Analgesic Tablets

• Iliadin Mini Nasal Drops

• Iliadin Mini Paediatric Nasal Drops

• Imarale Agba Suspension

• Imarale Omode Suspension

• Importal

• Inabrin Tablets 200mg

• Indian Brandy Solution

• Indigestion Mixture (Boots)

• Indigestion Mixture (Thornton and Ross)

• Indigestion Mixture (William Ransom)

• Indigo Indigestion Lozenges

• Infra-Care Baby Bath

• Influenza and Cold Mixture 2315 (Wright Layman and Umney)

• Inhalit Liquid Inhalation

• Innoxa Finishing Touch Loose Powder

• Innoxa Moisturised Liquid Make-Up

• Inoven Caplets

• Iodinated Glycerol Elixir 60 mg/5 ml

• Iodised Vitamin Capsules

• Iodo-Ephedrine Mixture

• Ipecacuanha Pills 20 mg

• Ipecacuanha and Morphine Mixture BP

• Ipecacuanha and Squill Linctus Paediatric BPC

• Ipsel Hygienic Babysalve

• Irofol C

• Iron and Brewers Yeast Tablets (3M Health Care)

• Iron and Vitamin Tablets (Davidson)

• Iron Formula Tablets (Rodale)

• Iron Jelloids Tablets

• Iron Tonic Tablets (Boots)

• Ironorm Capsules

• Ironorm Tonic

• Ironplan Capsules

• Ivy Tablets (Ayrton Saunders)

• Jaap’s Health Salts

• Jacksons All Fours Cough Mixture

• Jacksons Febrifuge

• Jambomins Tablets

• Jenners Suspension

• Jenners Tablets

• Jochem Hormone Hair Preparation

• Johnson and Johnson Baby Bath

• Johnson and Johnson Baby Cream

• Johnson and Johnson Baby Lotion

• Johnson and Johnson Baby Oil

• Johnson and Johnson Baby Powder

• Johnson and Johnson Baby Shampoo

• Jolen Creme Bleach

• Jordans Crunchy Bar

• Junamac

• Jung Junipah Tablets

• Junior Cabdrivers Linctus

• Junior Disprin Tablets

• Junior Disprol Suspension

• Junior Disprol Tablets

• Junior Ex-Lax Chocolate Tablets

• Junior Lemsip Powder

• Junior Meltus Cough and Catarrh Linctus

• Junior Mucron Liquid

• Junior Paraclear Tablets

• Junior Tablets (Rodale)

• Juno-Junipah Mineral Salts

• Juvel Elixir

• Juvel Tablets

• Jevela Gluten-Free Sage and Onion Stuffing Mix

• Karvol Capsules

• Kelsoak 2 Solution

• Kelvinol 2 Wetting Solution

• Kenco Instant Decaffeinated Coffee

• Kendales Adult Cough Syrup

• Kendales Cherry Linctus

• Kest Tablets

• Ketazolam Capsules 15 mg

• Ketazolam Capsules 30 mg

• Ketazolam Capsules 45 mg

• Keybells Linctus of Glycerine, Lemon and Ipecacuanha

• Kingo Cough Syrup

• Koladex Tablets

• Kolanticon Tablets

• Kolanticon Wafers

• Kolantyl Gel

• Krauses Cough Linctus

• Kruschen Salts

• Kuralax Herbs

• Labiton Kola Tonic

• Laboprin Tablets

• Lac Bismuth Mixture

• Lactaid Lactase enzyme for milk drops

• Lactaid Lactase enzyme tablets

• Lactaid Lactose reduced skimmed and whole milk UHT

• Lacto Calamine

• Laevoral

• Lamberts Evening Primrose Oil 250mg Capsules

• Lamberts Evening Primrose Oil 500mg Capsules

• Lamberts Evening Primrose Oil 1000mg Capsules

• Lamberts L-Threonine 500mg Capsules

• Lamberts Protein Deficiency Formula Capsules

• Lance B and C Tablets

• Lane’s Cut-a-Cough

• Lane’s Laxative Herb Tablets

• Lane’s Sage and Garlic Catarrh Remedy

• Lantigen B

• Lavender Bath

• Laxaliver Pills

• Laxatabs Leoren

• Laxipurg Tablets

• Laxoberal Elixir

• LC 65 Cleaning Solution

• Lederplex Capsules

• Lederplex Liquid

• Lejfibre Biscuit

• Lem-Plus Hot Lemon Drink

• Lemeze Cough Syrup

• Lemon Eno Powder

• Lemon Flu-Cold Concentrated Syrup

• Lemon Glycerine and Honey Cough Syrup Compound (Carter Bond)

• Lemon Glycerine and Honey Lung Mixture (Whitehall Laboratories)

• Lemon Glycerine and Ipecac Cough Syrup Compound (Carter Bond)

• Lemon Juice, Glycerine and Honey A S Syrup (Ayrton Saunders)

• Lemon Linctus 1-472

• Lemsip Expectorant

• Lemsip Linctus

• Lemsip Powder

• Lendormin Tablets 0.125 mg

• Lendormin Tablets 0.25 mg

• Lensept Solution

• Lensine 5 All in One Solution

• Lensplus Sterile Saline Spray

• Lensrins Solution

• Leoren Tonic Tablets

• Lexotan Tablets 1.5 mg

• Lexotan Tablets 3 mg

• Lexotan Tablets 6 mg

• Libraxin Tablets

• Librium Capsules 5 mg

• Librium Capsules 10 mg

• Librium Tablets 5 mg

• Librium Tablets 10 mg

• Librium Tablets 25 mg

• Librofem Tablets

• Lightning Cough Remedy Solution (Potters)

• Limbitrol Capsules “5”

• Limbitrol Capsules “10”

• Linctifed Expectorant

• Linctifed Expectorant Paediatric

• Linctoid C

• Linituss

• Linoleic Acid

• Linus Vitamin C Powder

• Lipoflavonoid Capsules

• Lipotriad Capsules

• Lipotriad Liquid

• Liqufruta Blackcurrant Cough Medicine

• Liqufruta Honey and Lemon Cough Medicine

• Liqufruta Medica

• Liqufruta Medica Garlic Flavoured Cough Medicine

• Liquid Formula (Food Concentrate) (Rodale)

• Liquid Paraffin and Phenolphthalein Emulsion BP

• Liquid Paraffin Emulsion with Cascara BPC

• Liquifilm Wetting Solution

• Listerine Antiseptic Mouthwash

• Listermint Mouthwash

• Liver Herbs (Hall's)

• Livibron Mixture

• Loasid Tablets

• Lobak Tablets

• Lofthouse’s Original Fisherman’s Friend Honey Cough Syrup

• London Herb and Spice Herbal Tea Bags

• Loramet Capsules 1 mg

• Loramet Tablets 0.5 mg

• Loramet Tablets 1 mg

• Lotussin Cough Syrup

• L-Threonine Capsules

• L-Threonine Tablets

• Lucozade

• Luma Bath Salts

• Lung Balsam (Rusco)

• Lyons Ground Coffee Beans

• Lypsyl Lemon

• Lypsyl Mint

• Lypsyl Original

• Lysaldin

• M and B Children’s Cough Linctus

• Maalox Concentrate Suspension

• Maalox Plus Tablets

• Mackenzies Smelling Salts

• Maclean Indigestion Power

• Maclean Indigestion Tablets

• Macleans Toothpaste

• Magaldrate Tablets

• Mainstay Pure Cod Liver Oil

• Male Gland Double Strength Supplement Tablets

• Male Sex Hormone Tablets (Diopharm)

• Malinal Plus Tablets

• Malinal Suspension 500 mg/5 ml

• Malinal Tablets 500 mg

• Malt Extract with Cod Liver Oil and Chemical Food (Distillers)

• Malt Extract with Cod Liver Oil BPC and Hypophosphites (Distillers)

• Malt Extract with Cod Liver Oil BPC Soft Extract (Jeffreys Miller)

• Malt Extract with Haemoglobin and Vitamins Syrup (Distillers)

• Malt Extract with Halibut Liver-Oil Syrup (Distillers)

• Mandarin Tablets

• Manna Herbal Rheumapainaway Tablets

• Marvel

• Matthew Cough Mixture

• Maturaplus Tablets

• Max Factor Face Powder

• Max Factor Pan-Stik

• Maxivits Tablets

• Medathlon Aspirin Tablets 300 mg

• Medazepam Capsules 5 mg

• Medazepam Capsules 10 mg

• Medex Elixir

• Mediclean Soft Lens Solution

• Medilax Tablets

• Medipain Tablets

• Medised Suspension

• Medised Tablets

• Medisoak Soft Lens Solution

• Meditus Syrup

• Medocodene Tablets

• Meggeson Dyspepsia Tablets

• Melissin Syrup

• Melo Brand Glycerin Lemon and Honey with Ipecac

• Meloids Lozenges

• Menthacol Liquid

• Menthells Pellet/Pill

• Menthol and Benzoin Inhalation BP

• Menthol and Eucalyptus (M in P) Pastilles (Thomas Guest)

• Menthol Inhalation

• Mentholated Balsam (Loveridge)

• Mentholated Balsam (Savory and Moore)

• Mentholated Balsam (Wright Layman and Umney)

• Mentholated Balsam Mixture (Pilsworth Manufacturing)

• Mentholatum Balm

• Mentholatum Nasal Inhaler

• Metatone

• Methylcisteine Tablets 100 mg

• Micaveen

• Midro-Tea Power

• Milgard Baby Cleansing Milk

• Milk of Magnesia Tablets

• Mil-Par Suspension

• Milupa 7 Cereal Breakfast

• Milupa Aptamil Baby Milk

• Milupa Camomile Infant Drink

• Milupa Fennel Variety Infant Drink

• Milupa Harvest Muesli Breakfast

• Milupa Modified Yoghurt

• Milupa Special Formula HN25

• Minadex Syrup

• Minamino Syrup

• Minivits Tablets

• Minoxidil Cream

• Minoxidil Lotion

• Minoxidil Ointment

• Minoxidil Solution (for external use)

• Mira Flow Cleaning Solution

• Mira Flow Soft Lens Solution

• Mira Soak Lens Soaking Solution

• Mira Sol Soft Lens Solution

• Mitchell’s Wool Fat Soap

• Modifast Nutritionally Complete Supplemented Fasting Formula

• Mogadon Capsules 5 mg

• Mogadon Tablets 5 mg

• Moorland Indigestion Tablets

• Morning Glory Tablets

• Morny Lavender Talc

• Mrs Cullen’s Lemsoothe Powder

• Mrs Cullen’s Powders

• Mu-Cron Tablets

• Mucodyne Capsules

• Mucodyne Syrup

• Mucodyne Forte Syrup

• Mucodyne Forte Tablets

• Mucodyne Paediatric Syrup

• Mucofalk Sachets

• Mucolex Syrup

• Mucolex Tablets

• Mucron Liquid

• Muflin Linctus

• Multi-Vitamin Tablets (English Grains)

• Multivitamin Capsules (Regent Laboratories)

• Multivitamin Tablets (Approved Prescription Services)

• Multivitamin Tablets (Chemipharm)

• Multivitamin Tablets (Evans Medical)

• Multivitamin Tablets (UAC International)

• Multivitamin with Mineral Capsules (Potters)

• Multivitamin with Minerals Tablets (Chemipharm)

• Multivite Pellets

• Multone Tablets

• My Baby Cough Syrup

• Mycolactine Tablets

• Mylanta Liquid

• Mylanta Tablets

• Myolgin Tablets

• N Tonic Syrup (Cupal)

• N-300 Capsules

• Napoloids Tablets

• Napsalgesic Tablets

• Natex 12A Tablets

• Natural Bran

• Natural Herb Laxative Tablets (Brome and Schimmer)

• Natural Herb Laxative Tablets (Kerbina)

• Natural Herb Tablets (Dorwest)

• Natural Herb Tablets (Kerbina)

• Natural Herb Tablets (Lane)

• Naturavite Tablets

• Naudicelle

• Neo-Cytamen Injection 250 mcg/ml

• Neo-Cytamen Injection 1000 mcg/ml

• Neoklenz Powder

• Neophyrn Nasal Drops

• Neophyrn Nasal Spray

• Nescafe Instant Coffee

• Nestle Nativa HA

• Nethaprin Expectorant

• Neuro Phosphates

• Neurodyne Capsules

• Neutradol Concentrated Air Deodoriser

• Neutradonna Powder

• Neutradonna Sed Powder

• Neutradonna Sed Tablets

• Neutradonna Tablets

• Neutrogena Soap

• Neutrolactis Tablets

• New Formula Beechams Powders Capsules

• New Life Herbs

• New Life Tablets

• Newton’s Children’s Cough Treatment

• Newton’s Cough Mixture for Adults

• Nezcaam Syrup

• Nicobrevin

• Nicorette

• Nicorette Plus

• Nilbite

• Nirolex Expectorant Linctus

• Nitrados Tablets 5 mg

• Nitrazepam Capsules 5 mg

• Nivea

• No 177 Tablets (Leoren)

• Nobrium Capsules 5 mg

• Nobrium Capsules 10 mg

• Nocold Tablets

• Noctamid Tablets 0·5 mg

• Noctamid Tablets 1 mg

• Noctesed Tablets 5 mg

• Noradran Bronchial Syrup

• Norgesic Tablets

• Normax Capsules

• Normison Capsules 10 mg

• Normison Capsules 20 mg

• Norvits Syrup

• Noscapine Linctus BP

• Novasil Antacid Tablets

• Novasil Antacid Viscous Suspension

• Nucross Coconut Oil

• Nulacin Tablets

• Nurodol Tablets

• Nurofen Tablets 200 mg

• Nurofen Soluble Tablets

• Nurse Sykes Bronchial Balsam

• Nurse Sykes Powders

• Nu-Soft Baby Oil

• Nux Vomica Acid Mixture

• Nux Vomica Alkaline Mixture

• Nux Vomica Elixir BPC

• Nylax Tablets

• Octovit Tablets

• Oilatum Bar

• Oilatum Soap

• Olbas Oil

• Omeiri Iron Tonic Tablets

• Omilcaf Suspension

• Onadox 118 Tablets

• One Gram C Capsule

• Opas Powder

• Opas Tablets

• Opobyl Bailly Pills

• Oral B Plaque Check Disclosing Tablets

• Orange and Halibut Vitamins (Kirby Warrick Pharmaceuticals)

• Organidin Elixir

• Organidin Solution

• Organidin Tablets

• Original Indigestion Tablets (Boots)

• Orovite Elixir

• Orovite Tablets

• Orovite 7

• Orthoxicol Syrup

• Ostermilk Complete Formula

• Ostermilk Two Milk Powder

• Otrivine Nasal Drops 0·05%

• Otrivine Nasal Drops 0·1%

• Otrivine Nasal Spray 0·1%

• Otrivine-Antistin Nasal Drops

• Otrivine-Antistin Nasal Spray

• Overnight Bedtime Cold Medicine

• Owbridge’s Cough Mixture

• Oxanid Tablets 10 mg

• Oxanid Tablets 15 mg

• Oxanid Tablets 30 mg

• Oxymetazoline Hydrochloride Nasal Drops 0·025%

• Oxymetazoline Hydrochloride Nasal Drops 0·05%

• Oxymetazoline Hydrochloride Nasal Spray 0·05%

• Oxysept 1 Disinfecting Solution

• Oxysept 2 Rinsing, Neutralising and Storing Solution

• Ozium 500 Air Sanitizer

• Ozium 1500 Air Sanitizer

• Ozium 3000

• Pacidal Tablets

• Paedo-Sed Syrup

• Pain Relief Tablets (Cox)

• Pain Relief Tablets (Davidson)

• Pameton Tablets

• Panacron Nasal Spray

• Panacron Tablets

• Panadeine Co Tablets

• Panadeine Forte Tablets

• Panadeine Soluble Effervescent Tablets

• Panadeine Tablets

• Panadol Caplets

• Panadol Extra Tablets

• Panadol Junior Sachets

• Panadol Soluble Tablets

• Panadol Tablets

• Panaleve Junior

• Panasorb Tablets

• Panets Tablets

• Pango Pain Paracetamol Codeine Tablets (Cupal)

• Pantene Hair Tonic

• Papain Compound Tablets

• Paprika Tablets (Kerbina)

• Para-Seltzer Effervescent Tablets

• Paracetamol and Caffeine Capsules

• Paracetamol and Caffeine Tablets

• Paracetamol DC Tablets

• Paracetamol Tablets Soluble (Boots)

• Paracetamol Tablets, Sorbitol Basis 500 mg

• Paracets Tablets 500 mg

• Paraclear Tablets

• Paracodol Capsules

• Paracodol Tablets

• Paradeine R Tablets

• Paragesic Effervescent Tablets

• Parahypon Tablets

• Parake Tablets

• Paralgin Tablets

• Paramin Capsules

• Paramol Tablets

• Paranorm Cough Syrup

• Pardale Tablets

• Parenamps Intramuscular Injection

• Pastilaids Pastilles

• Pavacol Cough Syrup

• Paxadon Tablets

• Paxalgesic Tablets

• Paxidal Tablets

• Paynocil Tablets

• PEM Linctus

• Penetrol Inhalant

• Pentazocine-Aspirin Compound Tablets

• Peplax Peppermint Flavoured Laxative Tablets

• Peppermint Indigestion Tablets (Boots)

• Pepto-Bismol Suspension

• Pernivit Tablets

• Persomnia Tablets

• Petrolagar Emulsion Plain

• Petrolagar Emulsion with Phenolphthalein

• PF Plus Tablets

• Pharmacin Capsules

• Pharmacin Effervescent Plus C Tablets

• Pharmacin Effervescent Tablets 325 mg

• Pharmaton Capsules

• Pharmidone Tablets

• Phenergan Compound Expectorant Linctus

• Phenolphthalein Compound Pills BPC

• Phenolphthalein Compound Tablets BPC 1963

• Phenolphthalein Tablets BP

• Phensedyl Cough Linctus

• Phensic Tablets

• Phensic 2 Tablets

• Phenylephrine Hydrochloride Nasal Drops 0·25%

• Phenylephrine Hydrochloride Nasal Spray 0.5%

• Phillips Iron Tonic Tablets

• Phillips Tonic Yeast Tablets

• Phillips' Toothpaste

• Phisoderm

• Pholcolix Syrup

• Pholcomed D Linctus

• Pholcomed Diabetic Forte Linctus

• Pholcomed Expectorant

• Pholcomed Forte Linctus

• Pholcomed Linctus

• Pholcomed Pastilles

• Pholtex Syrup

• Pholtussa Mixture

• Phosferine Liquid

• Phosferine Multi-Vitamin Liquid

• Phosferine Tablets

• Phyllosan Tablets

• Physeptone Linctus

• Pile Mixture (Ayrton Saunders)

• Pile Tablets (Ayrton Saunders)

• Pine Catarrh Drops Lozenges

• Piz Buin Children’s Balm SPF 8

• Piz Buin Creme Factor 6

• Piz Buin Creme Factor 8

• Piz Buin Lip Protection Stick SPF 8

• Piz Buin SPF 6 Lotion

• Piz Buin SPF 8 Lotion

• Plax Anti-Plaque Pre-Brushing Rinse

• Plenamin Super

• Plenivite with Iron Tablets

• Pliagel Soft Lens Solution

• Plurivite M Tablets

• Plurivite Tablets

• Poli-grip Denture Fixative Cream

• Polyalk Gel

• Polyalk Tablets

• Polyvite Capsules

• Potaba + 6 Capsules

• Potaba + 6 Tablets

• Potassium Bromide and Nux Vomica Mixture BPC 1963

• Powdered Bran Tablets 2 g

• Power Plus Super Multivitamin and Mineral Capsules

• Power GLA 65 (Borage Oil) Capsules

• Powerin Tablets

• PP Tablets

• PR Tablets

• Prazepam Tablets 10 mg

• PRD 200 Tablets 600 mg

• Preflex Solution

• Pregnadon Tablets

• Pregnavite Forte Tablets

• Premit Tablets 20 mg

• Prenatal Dri-Kaps Capsules

• Prenatol Anti Stretch Mark Cream

• Primes Premiums Tablets

• Priory Cleansing Herbs Powder

• Procol Capsules

• Proctofibe Tablets

• Prodexin Tablets

• Proflex Tablets 200 mg

• Progress Powder

• Propain Tablets

• Pro-Plus He-Vite Elixir

• Proteolised Liver Tablets

• Pro-Vitamin A Capsules (Rodale)

• Pru Sen Tablet Bar

• Prymecare Tablets for Soft and Gas Permeable Lenses

• Prymeclean Cleaning Solution for Soft Lenses

• Prymesoak Soaking Solution for Soft Lenses

• Pulmo Bailly Liquid

• Purgoids Tablets

• Pyridoxine Tablets, Slow 100 mg

• Quick Action Cough Cure (Brian C Spencer)

• Quiet Life Tablets

• Rabenhorst Tomato Juice

• Raspberry Tablets No. B039

• Rayglo Chest Rub Ointment

• Rayglo Laxative Tablets

• Reactivan Tablets

• Red Catarrh Pastilles (Baldwin)

• Redelan Effervescent Tablets

• Redoxon Adult Multivitamin Tablets

• Redoxon C Effervescent Tablets 1 g

• Redoxon C Tablets 25 mg

• Redoxon C Tablets 50 mg

• Redoxon C Tablets 200 mg

• Redoxon C Tablets 250 mg

• Redoxon C Tablets 500 mg

• Redoxon Children’s Multivitamin Tablets

• Redoxon Effervescent Tablets 1 g

• Regaine

• Regina Royal Jelly Capsules

• Reg-U-Lett Tablets

• Relanium Tablets 2 mg

• Relanium Tablets 5 mg

• Relanium Tablets 10 mg

• Relcol Tablets

• Remnos Tablets 5 mg

• Remnos Tablets 10 mg

• Rennie Tablets

• Rennie Gold Tablets

• Rennie Plus Tablets

• Resolve Granules

• Respaton

• Rheumavit Tablets

• Rhuaka Herbal Syrup

• Rhuaka Tablets

• Rhubarb and Soda Mixture Ammoniated BP

• Rhubarb Compound Mixture BPC

• Rhubarb Mixture Compound Paediatric BPC

• Ribena

• Riddovydrin Liquid

• Rinurel Linctus

• Rinurel Tablets

• Rite-Diet Diabetic Cherry Cake

• Rite-Diet Diabetic Fruit Cake

• Rite-Diet Gluten-Free Baking Powder

• Rite-Diet Gluten-Free Biscuits (chocolate chip cookies; half-coated chocolate biscuit; half covered chocolate digestive biscuit; custard cream biscuit; Lincoln biscuit; shortcake biscuit; sultana biscuit; soya bran)

• Rite-Diet Gluten-Free Canned Rich Fruit Cake

• Rite-Diet Gluten-Free Crunchy Bars

• Rite-Diet Gluten-Free Muesli Cookies

• Rite-Diet Macaroni in Mushroom Sauce, Low Protein/Gluten Free

• Rite-Diet Spaghetti with Tomato Sauce, Low Protein/Gluten-Free

• Robaxisal Forte Tablets

• Roberts Aspirin and Caffeine Tablets

• Robinsons Baby Rice

• Robitussin AC Liquid

• Robitussin Cough Soother

• Robitussin Cough Soother Junior Formula

• Robitussin Expectorant

• Robitussin Expectorant Plus

• Robitussin Liquid

• Robitussin Plus Liquid

• Robitussin Syrup

• RoC Compact Cleanser

• RoC Eye Make-Up Remover Lotion

• RoC Foundation Cream

• RoC Vitamin Cream

• Rock Salmon Cough Mixture

• Rohypnol Tablets 1 mg

• Roscorbic Effervescent Tablets

• Roscorbic Tablets 25 mg

• Roscorbic Tablets 50 mg

• Roscorbic Tablets 200 mg

• Roscorbic Tablets 500 mg

• Rose Hip C-100 Capsules

• Rose Hip C-200 Capsules

• Rose Hip Tablets (English Grains)

• Rose Hip Tablets (Potters)

• Rose Hip Tablets (Roberts)

• Rosemary Bath

• Rosmax Syrup

• Roter Tablets

• Rovigon

• Rubelix Syrup

• Rubraton B Elixir

• Ruby Tonic Tablets (Jacksons)

• Rum Cough Elixir

• Ruthmol

• Rutin Plus Tablets (Gerard)

• Safapryn Tablets

• Safapryn-Co Tablets

• Safflower Seed Oil

• Sainsbury’s Aspirin Tablets 300 mg

• Sainsbury’s Cold Powders with Blackcurrant

• Sainsbury’s Hot Lemon Powders

• Sainsbury’s Indigestion Tablets

• Sainsbury’s Junior Soluble Aspirin Tablets

• Sainsbury’s Paracetamol Tablets 500 mg

• Sainsbury’s Soluble Aspirin Tablets

• St Clement’s Fruit Juice Concentrate

• Salzone Syrup

• Salzone Tablets 500 mg

• Sanatogen Junior Vitamins Tablets

• Sanatogen Multivitamins Plus Iron (Formula One) Tablets

• Sanatogen Multivitamins Tablets

• Sanatogen Nerve Tonic Powder

• Sanatogen Selected Multivitamins Plus Iron (Formula Two) Tablets

• Sanatogen Tonic

• Sancos Compound Linctus

• Sancos Syrup

• Savant Tablets

• Savlon Baby Care Baby Bath

• Savlon Baby Care Cream

• Savlon Baby Care Lotion

• Savlon Baby Care Oil

• Savlon Baby Care Powder

• Savlon Baby Care Shampoo

• Savlon Baby Care Soap

• Saxin

• SBL Junior Cough Linctus

• SBL Soothing Bronchial Linctus

• Schar Gluten Free Sponge Cake

• Scholl Foot Refresher Spray

• Scott’s Cod Liver Oil Capsules

• Scott’s Emulsion

• Scott’s Husky Biscuits

• Seaweed Vitamin A Ester BP and Vitamin D BP Capsules (Regent Laboratories)

• Sebbix Shampoo

• Seclodin Capsules

• Sedazin Tablets 1 mg

• Sedazin Tablets 2.5 mg

• Selora Sodium-free Salt Substitute

• Selsun Soft Conditioner

• Senlax Tablets

• Senna Laxative Tablets (Boots)

• Senna Tablets (Potters)

• Senokot Tablets

• Senotabs Tablets

• Sensodyne Toothpaste

• Serenid D Tablets 10 mg

• Serenid D Tablets 15 mg

• Serenid Forte Capsules 30 mg

• Sertin Tablets

• Setamol Soluble Tablets

• Setlers Extra Strength Tablets

• Setlers Liquid

• Setlers Tablets

• Seven Seas Cod Liver Oil

• Seven Seas Formula 70 Multivitamin Multimineral Capsules

• Seven Seas Malt and Cod Liver Oil

• Seven Seas Orange Syrup and Cod Liver Oil

• Seven Seas Pure Cod Liver Oil Capsules

• Seven Seas Start Right Cod Liver Oil for Babies

• Sidros Tablets

• Silk-Lax Tablets

• Siloxyl Suspension

• Siloxyl Tablets

• Simeco Suspension

• Simeco Tablets

• Simple Hair Conditioner

• Simple Shampoo

• Simple Soap

• Sine-Off Tablets

• Sinitol Capsules

• Sinutab Tablets

• Sionon Sweetner

• Skin Glow Capsules

• SMA Gold Cap Powder and Ready-to-Feed

• SMA Powder and Concentrated Liquid

• Snufflebabe Vapour Rub

• Soaclens Solution

• Softtab Soft Lens Care Tablets

• Solis Capsules 2 mg

• Solis Capsules 5 mg

• Solis Capsules 10 mg

• Solmin Tablets

• Solpadeine Capsules

• Solpadeine Forte Tablets

• Solpadeine Tablets Effervescent

• Solprin Tablets

• Soluble Aspirin Tablets for Children (Boots)

• Soluble Phensic Tablets

• Solusol Solution

• Somnite Suspension 2.5 mg/5 ml

• Somnite Tablets 5 mg

• Soquette Soaking Solution

• Sovol Liquid

• Sovol Tablets

• Soya Powder and Nicotinamide Tablets

• Special Stomach Powder (Halls)

• Spectraban 4 Lotion

• SPHP Tablets

• Squill Linctus Opiate BP (Gee’s Linctus)

• Squill Linctus Opiate, Paediatric, BP

• Squire’s Soonax Tablets

• SR2310 Expectorant

• SR Toothpaste (Gibbs)

• Staffords Mild Aperient Tablets

• Staffords Strong Aperient Tablets

• Steri-Clens Solution

• Steri-Solve Soft Lens Solution

• Sterling Health Salts Effervescent

• Sterling Indigestion Tablets

• Sterling Paracetamol Tablets

• Sterogyl Alcoholic Solution

• Stomach Aids Tablets

• Stomach Mixture (Herbal Laboratories)

• Stomach Mixture H138 (Southon Laboratories)

• Stomach Powder (Diopharm)

• Stomach Tablets (Ulter)

• Street’s Cough Mixture

• Strengthening Mixture (Hall's)

• Stress B Supplement Tablets

• Strychnine and Iron Mixture BPC 1963

• Strychnine Mixture BPC 1963

• Stute Diabetic Blackcurrant Jam

• Stute Diabetic Marmalade

• Sudafed Co Tablets

• Sudafed Expectorant

• Sudafed Linctus

• Sunerven Tablets

• Super Plenamins Tablets

• Super Yeast + C Tablets

• Superdrug Health Salts

• Surbex-T Tablets

• Surem Capsules 5 mg

• Surem Capsules 10 mg

• Surelax Laxative Tablets

• Sweetex

• Sylopal Suspension

• Sylphen Tablets

• Syn-Ergel

• Syndol Tablets

• Syrtussar Cough Syrup

• T-Zone Decongestant Tablets

• Tabasan Tablets

• Tablets No. B006

• Tablets No. B011

• Tablets No. B015

• Tablets No. B024

• Tablets No. B025

• Tablets No. B029

• Tablets No. B034

• Tablets No. B035

• Tablets No. B036

• Tablets No. B037

• Tablets No. B038

• Tablets No. B040

• Tablets No. B041

• Tablets No. B045

• Tablets No. B048

• Tablets No. B070

• Tablets No. 268A (Potters)

• Tablets to Formula A10

• Tablets to Formula A11

• Tablets to Formula A18

• Tablets to Formula A19

• Tablets to Formula A20

• Tablets to Formula A22

• Tablets to Formula A23

• Tablets to Formula A31

• Tablets to Formula A32

• Tablets to Formula A33

• Tablets to Formula A45

• Tablets to Formula A51

• Tablets to Formula A63

• Tablets to Formula A67

• Tablets to Formula A68

• Tablets to Formula A69

• Tablets to Formula A70

• Tablets to Formula A71

• Tablets to Formula A105

• Tablets to Formula A111

• Tablets to Formula A114

• Tablets to Formula A120

• Tablets to Formula A147

• Tablets to Formula A157

• Tablets to Formula A158

• Tablets to Formula A161

• Tablets to Formula A162

• Tablets to Formula A164

• Tablets to Formula A165

• Tablets to Formula A166

• Tablets to Formula A167

• Tablets to Formula A169

• Tablets to Formula A175

• Tablets to Formula A183

• Tablets to Formula A184

• Tablets to Formula A190

• Tablets to Formula A195

• Tablets to Formula A202

• Tablets to Formula A203

• Tablets to Formula A213

• Tablets to Formula A221

• Tablets to Formula A244

• Tablets to Formula A245

• Tablets to Formula A246

• Tablets to Formula A247

• Tablets to Formula A248

• Tablets to Formula A249

• Tablets to Formula A250

• Tablets to Formula A264

• Tablets to Formula A266

• Tablets to Formula A270

• Tablets to Formula A271

• Tablets to Formula A272

• Tablets to Formula A273

• Tablets to Formula A274

• Tablets to Formula A275

• Tablets to Formula A276

• Tablets to Formula A277

• Tablets to Formula A298

• Tablets to Formula A301

• Tablets to Formula A316

• Tablets to Formula BA6

• Tablets to Formula B10

• Tablets to Formula B15

• Tablets to Formula B18

• Tablets to Formula B19

• Tablets to Formula B20

• Tablets to Formula B21

• Tablets to Formula B22

• Tablets to Formula B25

• Tablets to Formula B26

• Tablets to Formula B29

• Tablets to Formula B41

• Tablets to Formula B48

• Tablets to Formula B51

• Tablets to Formula B56

• Tablets to Formula B58

• Tablets to Formula B64

• Tablets to Formula B65

• Tablets to Formula B66

• Tablets to Formula B67

• Tablets to Formula B68

• Tablets to Formula B70

• Tablets to Formula B71

• Tablets to Formula B72

• Tablets to Formula B73

• Tablets to Formula B74

• Tablets to Formula B75

• Tablets to Formula B76

• Tablets to Formula B77

• Tablets to Formula B78

• Tablets to Formula B79

• Tablets to Formula B80

• Tablets to Formula B81

• Tablets to Formula B82

• Tablets to Formula B83

• Tablets to Formula B85

• Tablets to Formula B86

• Tablets to Formula B87

• Tablets to Formula B90

• Tablets to Formula B91

• Tablets to Formula B93

• Tablets to Formula B94

• Tablets to Formula B96

• Tablets to Formula B98

• Tablets to Formula B100

• Tablets to Formula B102

• Tablets to Formula B104

• Tablets to Formula B117

• Tablets to Formula B118

• Tablets to Formula B120

• Tablets to Formula B122

• Tablets to Formula B124

• Tablets to Formula B128

• Tablets to Formula B141

• Tablets to Formula B143

• Tablets to Formula B145

• Tablets to Formula B148

• Tablets to Formula B156

• Tablets to Formula B157

• Tablets to Formula B158

• Tablets to Formula B160

• Tablets to Formula B163

• Tablets to Formula B169

• Tablets to Formula B178

• Tablets to Formula B180

• Tablets to Formula B181

• Tablets to Formula B182

• Tablets to Formula B190

• Tablets to Formula B193

• Tablets to Formula B207

• Tablets to Formula B209

• Tablets to Formula B210

• Tablets to Formula B211

• Tablets to Formula B212

• Tablets to Formula B213

• Tablets to Formula B214

• Tablets to Formula B215

• Tablets to Formula B216

• Tablets to Formula B217

• Tablets to Formula B218

• Tablets to Formula B222

• Tablets to Formula B223

• Tablets to Formula B224

• Tablets to Formula B225

• Tablets to Formula B227

• Tablets to Formula B228

• Tablets to Formula B231

• Tablets to Formula B234

• Tablets to Formula B235

• Tablets to Formula B236

• Tablets to Formula B243

• Tablets to Formula B248

• Tablets to Formula B250

• Tablets to Formula B251

• Tablets to Formula B252

• Tabmint Anti-Smoking Chewing Gum Tablets

• Tancolin Childrens Cough Linctus

• Tedral Expectorant

• Temazepam Gelthix Capsules

• Temazepam Planpak

• Tensium Tablets 2 mg

• Tensium Tablets 5 mg

• Tensium Tablets 10 mg

• Tercoda Elixir

• Tercolix Elixir

• Terpalin Elixir

• Terperoin Elixir

• Terpoin Antitussive

• Terrabron

• Three Noughts Cough Syrup

• Tidmans Bath Sea Salt

• Timotei Herbal Shampoo

• Titan Hard Cleanser

• Tixylix Cough Linctus

• Tolu Solution BP

• Tolu Compound Linctus Paediatric BP

• Tolu Syrup BP

• Tonatexa Mixture

• Tonic Tablets (Thomas Guest)

• Tonic Wines

• Tonivitan A and D Syrup

• Tonivitan B Syrup

• Tonivitan Capsules

• Top C Tablets

• Toptabs

• Total All Purpose Solution

• Totavit D R Capsules

• Totolin Paediatric Cough Syrup

• Tramil Capsules

• Trancoprin Tablets

• Transclean Cleaning Solution

• Transdrop

• Transoak Solution

• Transol Solution

• Tranxene Capsules 7.5 mg

• Tranxene Capsules 15 mg

• Tranxene Tablets 15 mg

• Triocos Linctus

• Triogesic Elixir

• Triogesic Tablets

• Triominic Syrup

• Triominic Tablets

• Triopaed Linctus

• Triotussic Suspension

• Triovit Tablets

• Triple Action Cold Relief Tablets

• Tritamyl Gluten-Free Bread Mix

• Tropium Capsules 5 mg

• Tropium Capsules 10 mg

• Tropium Tablets 5 mg

• Tropium Tablets 10 mg

• Tropium Tablets 25 mg

• Trufree Crispbran

• Tudor Rose Bay Rhum

• Tums Tablets

• Tusana Linctus

• Tussifans Syrup

• Tussimed Liquid

• Two-A-Day Iron Jelloids Tablets

• Tymasil

• Tysons Catarrh Syrup

• Udenum Gastric Vitamin Powder

• Ultracach Analgesic Capsules

• Ultradal Antacid Stomach Tablets

• Ultralief Tablets

• Uncoated Tablets to Formula A323

• Uncoated Tablets to Formula A325

• Unichem Baby Oil

• Unichem Chesty Cough Linctus

• Unichem Children’s Dry Cough Linctus

• Unichem Cold Relief Capsules

• Unichem Dry Cough Linctus

• Uniflu Tablets

• Unigesic Capsules

• Unigest Tablets

• Unisomnia Tablets 5 mg

• United Skin Care Programme (Uni Derm; Uni-Salve; Uni-Wash)

• Vagisil Feminine Powder

• Valium Capsules 2 mg

• Valium Capsules 5 mg

• Valium Syrup 2 mg/5 ml

• Valium Tablets 2 mg

• Valium Tablets 5 mg

• Valium Tablets 10 mg

• Valonorm Tonic Solution

• Valrelease Capsules

• Vanamil Tablets

• Vapex Inhalant

• Vaseline Intensive Care Lotion

• Vaseline Intensive Care Lotion Herbal and Aloe

• Veganin Tablets

• Veno’s Adult Formula Cough Mixture

• Veno’s Cough Mixture

• Veno’s Honey and Lemon Cough Mixture

• Veracolate Tablets

• Verdiviton Elixir

• Vervain Compound Tablets

• Vi-Daylin Syrup

• Vicks Coldcare Capsules

• Vicks Cremacoat Syrup

• Vicks Cremacoat Syrup with Doxylamine Succinate

• Vicks Cremacoat Syrup with Guaiphenesin

• Vicks Cremacoat Syrup with Paracetamol and Dextromethorphan

• Vicks Daymed

• Vicks Formula 44 Cough Mixture

• Vicks Inhaler

• Vicks Medinite

• Vicks Pectorex Solution

• Vicks Sinex Nasal Spray

• Vicks Vapo-Lem Powder Sachets

• Vicks Vapour Rub

• Videnal Tablets

• Vigour Aids Tablets

• Vigranon B Complex Tablets

• Vigranon B Syrup

• Vikelp Coated Tablets

• Vikonon Tablets

• Villescon Liquid

• Villescon Tablets

• Virvina Elixir

• Visclair Tablets

• Vita Diem Multi Vitamin Drops

• Vita-Six Capsules

• Vitalin Tablets

• Vitamin and Iron Tonic (Epitone) Solution

• Vitamin A and D Capsules BPC 1968 (Regent Laboratories)

• Vitamin A Ester and Vitamin D2 Capsules (Regent Laboratories)

• Vitamin A Ester Capsules (Regent Laboratories)

• Vitamin A Ester Conc, Alpha Tocopheral Acetate Nat Capsules (Regent Laboratories)

• Vitamin A 4500 Units and Vitamin D2 Capsules (Regent Laboratories)

• Vitamin A 6000 Units and Vitamin D2 Capsules (Regent Laboratories)

• Vitamin A, C and D Tablets (Approved Prescription Services)

• Vitamin A, D and C Tablets (Regent Laboratories)

• Vitamin B Complex Tablets (English Grains)

• Vitamin B Complex with Brewer’s Yeast Tablets (English Grains)

• Vitamin B1 Dried Yeast Powder (Distillers)

• Vitamin B1 Yeast Tablets (Distillers)

• Vitamin B12 Tablets 0.01 mg

• Vitamin B12 Tablets 0.025 mg

• Vitamin B12 Tablets 0.05 mg

• Vitamin B12 Tablets 0.10 mg

• Vitamin B12 Tablets 0.25 mg

• Vitamin B12 Tablets 0.5 mg

• Vitamin B12 Tablets 1 mg

• Vitamin C Tablets Effervescent 1 g

• Vitamin Capsules (Regent Laboratories)

• Vitamin Malt Extract with Orange Juice (Distillers)

• Vitamin Mineral Capsules (Regent Laboratories)

• Vitamin Tablets No. B077

• Vitamin Tablets No. B081

• Vitamin Tablets No. B084

• Vitaminised Iron and Yeast Tablets (Kirby Warrick Pharmaceuticals)

• Vitanorm Malt Extract

• Vitanorm Malt Extract Syrup

• Vitsafe’s CF Kaps Tablets

• Vitasafe’s WCF Kaps Tablets

• Vitathorne Chilblain Tablets

• Vitatrop Tablets

• Vitavel Powder for Syrup

• Vitavel Solution

• Vitepron Tablets

• Vitorange Tablets

• Vitrite Multi-Vitamin Syrup

• Vykmin Fortified Capsules

• W L Tablets

• Wallachol Syrup

• Wallachol Tablets

• Wate-on Emulsion

• Wate-on Emulsion Super

• Wate-on Tablets

• Wate-on Tablets Super

• Wate-on Tonic

• Waterhouses All Fours

• Wines

• Woodwards Nursery Cream

• Wrights Glucose with Vitamin D Powder

• Wrights Vaporizing Fluid

• Xanax Tablets 0.25 mg

• Xanax Tablets 0.5 mg

• Xanax Tablets 1.0 mg

• Yeast and B12 Tablets (English Grains)

• Yeast Plus Tablets (Thomas Guest)

• Yeast-Vite Tablets

• Yellow Phenolphthalein Tablets (any strength)

• Zactirin Tablets

• Zefringe Sachets

• Zendium Toothpaste

• Zubes Expectorant Cough Syrup

• Zubes Original Cough Mixture

• Zyriton Expectorant Linctus

SCHEDULE 11 DRUGS TO BE PRESCRIBED UNDER PHARMACEUTICAL SERVICES ONLY IN CERTAIN CIRCUMSTANCES

Column 1	Column 2	Column 3
Drug	Patient	Condition
Acetylcysteine Granules	Any patient	Treatment of abdominal complications associated with cystic fibrosis
Carbocisteine	A patient under the age of 18 who has undergone a tracheostomy	Treatment of any condition which through damage or disease, affects the airways and has required a tracheostomy
Clobazam	Any patient	Treatment of epilepsy
Pregnavite Forte F	A woman who has previously given birth to a child (whether or not born alive) with a defect of the neural tube or aborted a foetus with such a defect	Reduction of the risk of spina bifida or anencephaly in a child which may be born to the patient

Regulation 3(2) Schedule 2 Paragraph 47

SCHEDULE 12 INFORMATION TO BE INCLUDED IN PRACTICE LEAFLETS

PERSONAL AND PROFESSIONAL DETAILS OF THE DOCTOR

1.  Full name.

2.  Sex.

3.  Medical qualifications registered by the General Medical Council.

4.  Date and place of first registration as medical practitioner.

PRACTICE INFORMATION

5.  The times approved by the FHSA during which the doctor is personally available for consultation by his patients at his practice premises.

6.  Whether an appointments system is operated by the doctor for consultation at his practice premises.

7.  If there is an appointments system, the method of obtaining a non-urgent appointment and the method of obtaining an urgent appointment.

8.  The method of obtaining a non-urgent domiciliary visit and the method of obtaining an urgent domiciliary visit.

9.  The doctor’s arrangements for providing personal medical services when he is not personally available.

10.  The method by which patients are to obtain repeat prescriptions from the doctor.

11.  If the doctor’s practice is a dispensing practice the arrangements for dispensing prescriptions.

12.  If the doctor provides clinics for his patients, their frequency, duration and purpose.

13.  The numbers of staff, other than doctors, assisting the doctor in his practice and a description of their roles.

14.  Whether or not the doctor provides child health surveillance services, contraceptive services, maternity medical services, minor surgery services.

15.  Whether the doctor works single handed, in partnership, part-time or on a job sharing basis, or within a group practice of doctors.

16.  The nature of any arrangements whereby the doctor or his staff receive patients' comments on his provision of general medical services.

17.  The geographical boundary of his practice area by reference to a sketch, diagram or plan.

18.  Whether the doctor’s practice premises have suitable access for all disabled patients and, if not, the reasons why they are unsuitable for particular types of disability.

19.  If an assistant is employed, details of that assistant as specified in paragraphs 1 to 5 of this Schedule.

20.  If the practice is either a general practitioner training practice, for the purposes of the National Health Service (Vocational Training) Regulations 1979(46), or undertakes the teaching of undergraduate medical students, the nature of the arrangements for drawing this to the attention of patients.

Regulation 3(2) Schedule 2, Paragraph 50

SCHEDULE 13 INFORMATION TO BE PROVIDED IN ANNUAL REPORTS

1.  The number of staff, other than doctors, assisting the doctor in his practice, by reference to—

(a) the total number but not by reference to their names;

(b) the principal duties and hours of employment of each employee;

(c) the qualifications of each employee;

(d) the relevant training undertaken by each employee during the preceding 5 years.

2.  The following information as respects the practice premises—

(a) any variations in relation to floor space, design or quality since the last annual report;

(b) any such variations anticipated in the course of the forthcoming period of 12 months.

3.  The following information as respects the referral of patients to other services under the Act during the period of the report:

(a) as respects those by the doctor to a specialist—

(i) the total number of patients referred as in-patients,

(ii) the total number of patients referred as out-patients,

by reference in each case to whichever of the following clinical specialities applies, and specifying in each case the name of the hospital concerned:

• General Surgical

• General Medical

• Orthopaedic

• Rheumatology (Physical Medicine)

• Ear, Nose and Throat

• Gynaecology

• Obstetrics

• Paediatrics

• Ophthalmology

• Psychiatry

• Geriatrics

• Dermatology

• Neurology

• Genito-urinary

• X-ray

• Pathology

• Others (including plastic surgery, accident or emergency and endocrinology); and

(b) the total number of cases of which the doctor is aware (by reference to the categories listed in sub-paragraph (a)) in which a patient referred himself to services under the Act.

4.  The doctor’s other commitment as a medical practitioner, with reference to—

(a) a description of any posts held; and

(b) a description of all work undertaken,

Including, in each case, the annual hourly commitment.

5.  The nature of any arrangements whereby the doctor or his staff received patients' comments on his provision of general medical services.

6.  The following information as respects orders for drugs and appliances:—

(a) whether the doctor’s practice has its own formulary;

(b) whether the doctor uses a separate formulary;

(c) the doctor’s arrangements for the issue of repeat prescriptions to patients.

(1)

1977 c. 49.

(2)

1980 c. 53.

(3)

1984 c. 48.

(4)

1990 c. 19.

(5)

As to the manner in which these and other powers may be exercised, see also section 103(3) of the Medicines Act 1968 (c. 67) as amended by section 22(4) of the Health and Medicines Act 1988 (c. 49).

(6)

1983 c. 41.

(7)

S.I. 1985/39.

(8)

S.I. 1981/432.

(9)

Section 41 was amended by paragraph 53 of Schedule 1 to, and by Schedule 3 to the Health Services Act 1980 (c. 53) and by S.I. 1985/39, article 7(13) and by paragraph 18 of Schedule 9 to the National Health Service and Community Care Act 1990 (c. 19).

(10)

Section 46 was amended by Schedule 8 to the Health and Social Security Act 1984 (c. 48) and by S.I. 1985/39, article 7(16).

(11)

S.I. 1976/615, as amended by S.I. 1982/699, 1987/409, 1987/1686 and 1992/247.

(12)

1975 c. 14.

(13)

See S.I. 1976/615 and 1987/1968.

(14)

1982 c. 24; section 17 was amended by section 20 of the Social Security Act 1985 (c. 53).

(15)

See S.I. 1985/1604, as amended by S.I. 1992/247.

(16)

1986 c. 50.

(17)

See S.I. 1987/235, as amended by S.I. 1991/2284.

(18)

1988 c. 53.

(19)

1977 c. 49; section 38 was amended by the Health and Social Security Act 1984 (c. 48), section 1(3), by S.I. 1985/39, article 7(11), and by the Health and Medicines Act 1988 (c. 49), section 13(1).

(20)

S.I. 1985/2066; the relevant amending instrument is S.I. 1986/2330.

(21)

1971 c. 38.

(22)

1968 c. 67. See S.I. 1983/1212 as amended by S.I. 1984/756, 1986/586, 1987/674, 1987/1250, 1988/2017 and 1989/1852.

(23)

S.I. 1992/664.

(24)

S.I. 1979/1644.

(25)

S.I. 1979/1644.

(26)

28 & 29 Vict. c.73.

(27)

7 & 8 Geo. 5 c.51.

(28)

2 & 3 Geo. 6 c.83.

(29)

2 & 3 Geo. 6 c.82.

(30)

5 & 6 Geo. 6 c.26.

(31)

10 & 11 Geo. 6 c.19.

(32)

15 & 16 Geo. 6 and 1 Eliz. 2 c.8.

(33)

1975 c. 14.

(34)

1975 c. 16.

(35)

1982 c. 24.

(36)

1986 c. 50.

(37)

1988 c. 7.

(38)

1979 c. 36.

(39)

1 and 2 Eliz. 2 c.72

(40)

1983 c. 20.

(41)

1974 c. 23.

(42)

11 & 12 Geo. 6 c.64.

(43)

7 & 8 Geo. 6 c.15.

(44)

14 & 15 Geo. 6 c.10.

(45)

1980 c. 9.

(46)

S.I. 1979/1644.